Pleural effusion

J10_PLEUREFFUSION

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — J90, J91* Hospital discharge: ICD-9 — 5111 Hospital discharge: ICD-8 — 511[1-2] Cause of death: ICD-10 — J90, J91* Cause of death: ICD-9 — 5111 Cause of death: ICD-8 — 511[1-2] 2 out of 7 registries used, show all original rules.	6324
4. Check minimum number of events None	6324
5. Include endpoints None	6324
6. Filter based on genotype QC (FinnGen only)	6324

Control definitions (FinnGen only)

Control exclude: J10_PLEURA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	J10_PLEUREFFUSION
CONTROL_EXCLUDE	J10_PLEURA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	J9[0-1]
HD_ICD_9	5111
HD_ICD_8	511[1-2]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	J9[0-1]
COD_ICD_9	5111
COD_ICD_8	511[1-2]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pleural effusion based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	49386	19428	29194
Only index persons	36664	14739	21925
Unadjusted period prevalence (%)
Whole population	0.71	0.56	0.82
Only index persons	0.72	0.54	0.84
Median age at first event (years)
Whole population	69.96	71.18	69.13
Only index persons	69.58	70.70	68.83

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6324	2176	4148
Unadjusted period prevalence (%)	1.45	0.74	1.83
Median age at first event (years)	69.04	66.29	70.48

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5662: Matched controls
56620

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.4

323.0

3523

18623

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.6

323.0

2610

10871

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

35.5

323.0

1388

513

GAC00

NOMESCO Finland

Biopsy of pleura

298.8

323.0

336

TGA30

NOMESCO Finland

Thoracocentesis

165.6

323.0

620

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

5.3

323.0

1394

3265

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

46.7

323.0

819

204

J94.8

ICD-10 Finland

Other specified pleural conditions

1246.3

323.0

938

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

7.7

323.0

849

1263

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

4503599627370496.0

323.0

5348

C03CA01

ATC

furosemide; systemic

3.2

323.0

3007

14704

R06.0

ICD-10 Finland

Dyspnoea

3.4

323.0

2204

8989

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

28.9

323.0

869

353

UGC12

NOMESCO Finland

Flexible bronchoscopy

6.4

323.0

1253

2424

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

33.1

308.1

410

133

J94.9

ICD-10 Finland

Pleural condition, unspecified

1593.7

306.7

296

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

155.5

266.4

281

GD1BA

NOMESCO Finland

Extensive X-ray examination of thorax

20.4

254.5

390

205

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.2

239.2

1514

5734

H02AB06

ATC

prednisolone; systemic

2.5

235.8

3133

18646

GAC01

NOMESCO Finland

Endoscopic biopsy of pleura

599.7

234.5

231

I50.9

ICD-10 Finland

Heart failure, unspecified

3.1

231.9

1592

6364

J96.1

ICD-10 Finland

Chronic respiratory failure

372.9

216.6

217

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

4.0

215.8

988

2861

Z51.5

ICD-10 Finland

Palliative care

4.6

213.2

812

1972

GA3AT

NOMESCO Finland

Pleural cytology with ultrasound guidance

102.3

205.8

226

N02AA05

ATC

oxycodone; systemic

3.0

204.8

1435

5742

JN4BD

NOMESCO Finland

Extensive body CT

3.4

197.4

1120

3842

C45.0

ICD-10 Finland

Mesothelioma of pleura

141.0

191.7

204

GAA96

NOMESCO Finland

Other open or percutaneous drainage of pleural cavity

65.6

190.0

221

J01MA14

ATC

moxifloxacin; systemic

3.9

188.2

866

2496

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

4.3

187.2

772

2012

GD1AD

NOMESCO Finland

Thorax CT examination

5.9

184.9

555

1023

J01MA12

ATC

levofloxacin; systemic

2.6

175.6

1563

7147

J91

ICD-10 Finland

Pleural effusion in conditions classified elsewhere

816.1

162.4

159

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

73.3

161.7

185

J86.9

ICD-10 Finland

Pyothorax without fistula

19.1

159.6

249

136

H02AB02

ATC

dexamethasone; systemic

3.3

156.9

884

2969

A03FA01

ATC

metoclopramide; systemic, rectal

2.5

156.4

1463

6807

130

Kela drug reimbursment

Malignant tumour

3.3

156.1

906

3111

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

8.3

154.2

358

456

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.9

151.5

1062

4147

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.1

137.0

877

3205

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.8

136.5

1021

4125

I50.0

ICD-10 Finland

Congestive heart failure

3.1

135.2

850

3065

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

4.8

133.1

473

1046

A04AA01

ATC

ondansetron; systemic, rectal

3.8

127.5

584

1645

JN4AD

NOMESCO Finland

Body CT examination

3.3

123.4

702

2348

A02BC02

ATC

pantoprazole; systemic

2.0

122.2

3720

27962

J92.9

ICD-10 Finland

Pleural plaque without asbestos

162.3

120.8

127

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

4.5

120.4

458

1084

C03DA01

ATC

spironolactone; oral

2.7

118.7

944

3926

R03BB04

ATC

tiotropium bromide; inhalant

2.7

114.8

886

3616

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

4.6

113.9

427

994

J96.0

ICD-10 Finland

Acute respiratory failure

553.5

110.2

109

51120

ICD-8 Finland

Pleurisy, Other specified forms of effusion, except tuberculous

+∞

105.5

101

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

103.3

938

4174

TPH04

NOMESCO Finland

Cathetrisation of vein

2.1

99.7

1392

7591

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

98.4

1254

6571

J98.1

ICD-10 Finland

Pulmonary collapse

205.5

97.7

101

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

96.0

1906

11898

B01AA03

ATC

warfarin; systemic

1.9

95.1

1732

10465

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

4.4

93.5

362

867

R03AC02

ATC

salbutamol; inhalant

1.8

92.2

2654

18717

ZX120

NOMESCO Finland

Intravenous

2.7

89.7

708

2895

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

3.5

89.6

453

1371

C07AB07

ATC

bisoprolol; oral

1.7

86.9

3082

23023

ZXD05

NOMESCO Finland

Urgent procedure

1.9

86.5

1852

11765

R50.9

ICD-10 Finland

Fever, unspecified

2.3

86.4

939

4539

R18

ICD-10 Finland

Ascites

6.5

86.1

234

373

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

9.5

86.0

182

197

WF049

NOMESCO Finland

Radiotherapy of metastasis

4.1

83.2

349

900

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

83.1

1441

8464

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

83.1

1896

12268

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

2.0

83.1

1282

7203

GAA31

NOMESCO Finland

Thoracoscopy

32.0

82.7

110

L01CA04

ATC

vinorelbine; systemic

13.4

81.4

145

111

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

408.2

81.1

9050/3-C38.4

ICD-O-3

Mesothelioma, malignant of pleura, NOS

111.7

81.1

J93.9

ICD-10 Finland

Pneumothorax, unspecified

278.4

80.7

TGC00

NOMESCO Finland

Bronchial lavation

5.1

80.4

268

548

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

3.4

79.6

422

1322

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

76.9

1184

6618

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

3.9

76.1

335

901

J93.8

ICD-10 Finland

Other pneumothorax

748.0

75.4

R02

ICPC

Shortness of breath/dyspnoea

2.3

75.4

787

3709

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.0

74.8

480

1719

B01AB05

ATC

enoxaparin; parenteral

1.8

74.7

1816

11892

A04AA02

ATC

granisetron; systemic, transdermal

3.1

72.8

440

1512

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.6

72.8

265

595

9052/3-C38.4

ICD-O-3

Epithelioid mesothelioma, malignant of pleura, NOS

351.4

69.7

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.8

69.7

1719

11255

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.7

68.7

2440

17745

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.9

68.5

448

1621

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

3.1

68.3

401

1350

J01FF01

ATC

clindamycin; systemic

1.8

67.7

1486

9354

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.7

67.7

1711

11261

P01BA02

ATC

hydroxychloroquine; oral

2.7

67.4

494

1919

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.3

66.6

682

3170

WX408

NOMESCO Finland

General anesthesy, balanced

1.8

66.5

1505

9560

WW500

NOMESCO Finland

Blood transfusion

3.3

65.9

352

1106

5119X

ICD-9 Finland

Pleurisy, Unspecified pleural effusion

+∞

65.7

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.9

65.0

417

1489

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

12.3

64.4

119

WZC30

NOMESCO Finland

Teaching

2.1

62.3

804

4144

J94.2

ICD-10 Finland

Haemothorax

164.3

62.1

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

61.0

1025

5857

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

60.9

840

4448

WX892

NOMESCO Finland

Monitored bed care

2.5

60.6

540

2334

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.4

59.6

537

2336

TGA10

NOMESCO Finland

Needle biopsy of pleura

+∞

59.5

TK800

NOMESCO Finland

Hemodialysis

4.6

59.5

214

475

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

6.3

58.7

161

260

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

58.3

539

2373

B01AB10

ATC

tinzaparin; parenteral

2.6

58.1

472

1941

I50.1

ICD-10 Finland

Left ventricular failure

2.6

57.6

447

1792

J01DB01

ATC

cefalexin; oral

1.6

57.4

4187

35913

XG410

NOMESCO Finland

Flow-volume spirometry

3.4

56.8

298

923

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

4.2

56.6

228

565

L03AA13

ATC

pegfilgrastim; parenteral

3.5

56.4

276

809

GAC97

NOMESCO Finland

Other endoscopic operation on pleura

45.1

54.5

N02AX02

ATC

tramadol; systemic, rectal

1.6

54.1

2354

17668

JN4CD

NOMESCO Finland

Very extensive body CT

3.1

53.4

320

1090

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.8

53.2

377

1429

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

3.5

52.5

259

764

GAC46

NOMESCO Finland

Partial decortication of pleura

61.6

52.4

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

6.9

51.9

133

196

128

Kela drug reimbursment

Cancers of female genital organs

6.2

50.7

140

229

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

50.2

924

5410

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

50.1

657

3391

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

7.9

50.0

117

151

R82

ICPC

Pleurisy/pleural effusion

92.6

49.9

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

7.2

49.4

123

174

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.3

49.2

496

2275

ZXE00

NOMESCO Finland

One hour or less

1.6

48.4

2043

15099

C01AA05

ATC

digoxin; systemic

2.0

48.1

726

3953

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

5.3

47.8

151

291

A07EC01

ATC

sulfasalazine; oral, rectal

2.3

46.8

460

2084

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.8

46.3

325

1224

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.7

46.0

211

587

I50

ICD-10 Finland

Heart failure

2.9

45.4

289

1023

L03AA02

ATC

filgrastim; parenteral

3.6

45.4

211

594

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.3

44.9

465

2158

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

9.8

44.9

5111B

ICD-9 Finland

Pleurisy, With effusion, with mention of a bacterial cause other than tuberculosis[PLEURITIS EXSUDATIVA ALIA DEFINITA]

+∞

44.8

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.6

44.6

343

1363

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.7

44.1

1028

6463

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

43.9

644

3460

WF004

NOMESCO Finland

Palliative radiotherapy

3.9

43.8

188

494

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

9.6

43.4

A41.9

ICD-10 Finland

Sepsis, unspecified

2.8

43.1

294

1088

R84

ICPC

Malignant neoplasm bronchus/lung

12.3

42.7

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

42.6

1941

14484

J01CA04

ATC

amoxicillin; systemic

1.5

42.4

3888

33615

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

42.2

621

3342

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

42.1

727

4143

192

Kela drug reimbursment

Fulvestrant

14.7

41.5

H02AB07

ATC

prednisone; oral

1.8

41.5

791

4661

R4110

NOMESCO Finland

Physiotherapy

1.6

41.3

1389

9630

N02BE01

ATC

paracetamol; systemic, rectal

1.6

41.2

4495

40251

GD5CD

NOMESCO Finland

Thorax and upper abdomen combined very extensive CT examination of

9.7

40.7

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

4.4

40.6

152

352

M04AA01

ATC

allopurinol; systemic

1.7

40.6

951

5975

L02BA03

ATC

fulvestrant; parenteral

13.9

40.5

XG466

NOMESCO Finland

Sleep oxymetry

3.3

40.4

215

673

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

2.2

40.2

427

1999

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

5.1

40.1

131

263

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.7

40.1

119

214

B03XA02

ATC

darbepoetin alfa; parenteral

3.8

40.0

175

468

N05CF01

ATC

zopiclone; oral

1.5

39.9

1798

13332

207

Kela drug reimbursment

Chronic arrhythmias

1.7

39.8

1018

6553

QBC00

NOMESCO Finland

Removal of foreign body from skin of trunk or subcutaneous tissue

27.2

39.4

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

39.2

1420

10005

R4190

NOMESCO Finland

Nutritional therapy

3.6

38.6

184

529

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.9

38.5

248

885

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

3.4

38.2

193

581

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

4.3

37.8

145

344

GAC37

NOMESCO Finland

Endoscopic chemical pleurodesis

+∞

37.5

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

37.4

582

3189

A46

ICD-10 Finland

Erysipelas

1.7

37.3

855

5321

Z2446

NOMESCO Finland

Social worker

2.3

36.8

346

1530

XGX10

NOMESCO Finland

Intrapleural ultrasonography

100.7

36.7

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

9.8

36.3

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.4

36.2

311

1313

GAB10

NOMESCO Finland

Antero- or postero-lateral thoracotomy

11.1

36.0

GAC30

NOMESCO Finland

Artificial pneumothorax

359.5

36.0

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.8

35.5

241

890

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

5.9

35.2

101

175

N03AX16

ATC

pregabalin; oral

1.6

35.1

1148

7855

L04AX01

ATC

azathioprine; systemic

2.8

35.0

229

826

1BA04

NOMESCO Finland

34.9

A04AA55

ATC

palonosetron, combinations; systemic

3.8

34.9

153

411

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.1

34.8

202

674

I30.9

ICD-10 Finland

Acute pericarditis, unspecified

9.2

34.6

GDA11

NOMESCO Finland

Thoracoscopic biopsy of lung

14.2

34.6

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.1

34.4

193

628

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

34.2

1616

12012

N18.8

ICD-10 Finland

Other chronic renal failure

2.8

34.1

228

833

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.2

34.0

385

1856

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

3.2

33.4

186

603

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

4.4

33.3

125

291

C38.4

ICD-10 Finland

Malignant neoplasm: Pleura

56.1

33.2

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

33.2

786

4927

A06AH03

ATC

naloxegol; oral

5.2

33.1

104

201

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

33.1

878

5681

A28

ICPC

Limited function/disability NOS

1.6

33.0

962

6380

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

6.5

32.8

136

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

3.4

32.5

161

478

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

10.4

32.5

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.2

32.3

346

1627

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.2

32.0

124

298

A16.5

ICD-10 Finland

Tuberculous pleurisy, without mention of bacteriological or histological confirmation

88.1

31.7

A15.6

ICD-10 Finland

Tuberculous pleurisy, confirmed bacteriologically and histologically

114.0

31.7

R04.2

ICD-10 Finland

Haemoptysis

2.6

31.5

244

974

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.3

31.2

305

1372

GAC43

NOMESCO Finland

Total decortication of pleura

160.8

30.7

SPAT1254

SPAT

Administration of medicine

1.6

30.5

815

5272

1501

Kela drug reimbursment

Palbociclib

11.5

30.5

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

3.9

30.4

130

342

J01FA06

ATC

roxithromycin; oral

1.4

30.3

1914

14982

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

6.1

30.3

140

GAC36

NOMESCO Finland

Chemical pleurodesis

+∞

30.2

J96.9

ICD-10 Finland

Respiratory failure, unspecified

38.3

30.2

L04AA06

ATC

mycophenolic acid; systemic

4.4

30.1

111

255

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

30.0

315

1467

N02AA01

ATC

morphine; systemic, rectal

3.8

29.6

128

341

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

3.5

29.5

142

413

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

29.5

418

2207

A02BC01

ATC

omeprazole; systemic

1.5

29.3

1473

11019

R95

ICPC

Chron obstructive pulmonary disease

2.8

29.3

191

688

C09AA05

ATC

ramipril; oral

1.4

29.3

1522

11459

L28

ICPC

Limited function/disability (L)

1.6

29.2

896

6004

D70.82

ICD-10 Finland

Drug-induced neutropenia

4.0

29.1

119

302

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.9

29.0

438

2368

L02BA01

ATC

tamoxifen; oral

2.9

28.7

182

643

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

28.6

807

5291

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.7

28.6

680

4254

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

4.1

28.5

112

274

J01AA02

ATC

doxycycline; systemic

1.4

28.4

3917

34922

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

4.2

28.4

109

261

N18.0

ICD-10 Finland

End-stage renal disease

3.9

28.4

118

304

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

28.3

372

1906

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

3.2

28.1

152

483

J94.0

ICD-10 Finland

Chylous effusion

+∞

28.1

5111A

ICD-9 Finland

Pleurisy, With effusion, with mention of a bacterial cause other than tuberculosis[PLEURITIS EXSUDATIVA BACTERICA]

+∞

28.1

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

28.0

224

908

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

2.2

28.0

289

1334

A11CC03

ATC

alfacalcidol; systemic

3.0

27.9

168

576

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

8.4

27.6

TGW99

NOMESCO Finland

Other minor procedure in thoracic surgery

15.6

27.6

GA2AT

NOMESCO Finland

Pleural biopsy with ultrasound guidance

47.4

27.4

AA1AD

NOMESCO Finland

CT of head and brain

1.5

27.4

1324

9805

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.8

27.3

187

694

XF600

NOMESCO Finland

Bloodpressure measurement

2.0

27.2

361

1854

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

5.2

27.2

164

A04AD12

ATC

aprepitant; systemic

3.8

27.2

119

321

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.8

27.1

116

307

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

12.0

26.9

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.0

26.7

355

1824

J98.6

ICD-10 Finland

Disorders of diaphragm

272.3

26.7

394

Kela drug reimbursment

Palbociclib

10.9

26.7

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.1

26.5

305

1477

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

2.4

26.5

225

945

K77

ICPC

Heart failure

2.9

26.4

164

574

A06AD11

ATC

lactulose; oral

1.5

26.3

916

6310

J86.00

ICD-10 Finland

Empyema with broncho-pleural fistula

16.3

26.2

B01AB04

ATC

dalteparin; parenteral

2.1

26.2

293

1402

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

4.2

26.1

102

249

Z3226

NOMESCO Finland

Physiotherapist

1.5

26.0

914

6308

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.7

26.0

183

691

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

25.9

903

6220

WX872

NOMESCO Finland

Intensive care

2.1

25.8

307

1508

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

3.8

25.8

113

305

JAL30

NOMESCO Finland

Omentectomy

5.4

25.7

146

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

10.1

25.6

155

Kela drug reimbursment

Afatinib and gefitinib

24.1

25.6

AN1

Coronary angiography

1.6

25.6

784

5236

R81

ICPC

Pneumonia

2.6

25.5

197

786

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

2.7

25.5

178

671

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

2.3

25.2

247

1115

M05BX04

ATC

denosumab; parenteral

2.2

25.1

279

1332

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

2.2

25.1

271

1276

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.3

25.1

232

1016

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.9

24.9

381

2068

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

3.0

24.8

149

510

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.0

24.8

352

1856

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

24.6

1933

15565

L02BG04

ATC

letrozole; oral

2.3

24.5

238

1069

XW000

NOMESCO Finland

Bone marrow biopsy

2.2

24.5

257

1196

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

5.2

24.2

148

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

24.1

766

5156

Z3231

NOMESCO Finland

Registered nurse

1.4

24.0

1402

10720

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

4.4

23.8

204

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

6.4

23.7

100

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

2.9

23.7

150

532

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.0

23.6

248

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

23.6

1370

10455

HA1AA

NOMESCO Finland

X-ray mammography

2.1

23.6

280

1377

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

4.5

23.5

188

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

4.8

23.5

166

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.9

23.5

149

530

115

Kela drug reimbursment

Breast cancer

2.0

23.5

315

1625

R05

ICD-10 Finland

Cough

1.5

23.4

876

6116

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

23.2

2091

17171

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

23.2

831

5748

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.3

23.1

212

928

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

3.6

23.0

105

294

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

22.9

328

1736

C56

ICD-10 Finland

Malignant neoplasm of ovary

9.1

22.9

D38.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Pleura

13.0

22.8

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

2.0

22.8

308

1592

C01DA14

ATC

isosorbide mononitrate; oral

1.4

22.6

1127

8347

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

5.2

22.6

139

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.8

22.5

432

2528

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

22.4

392

2228

I25.2

ICD-10 Finland

Old myocardial infarction

1.7

22.2

531

3318

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

22.2

745

5073

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

3.7

22.1

264

N05BA04

ATC

oxazepam; oral

1.4

22.0

1128

8396

Z2221

NOMESCO Finland

Medical doctor

1.4

22.0

1306

9986

L01XE33

ATC

[U] palbociclib; oral

11.1

21.8

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

21.8

282

1437

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

2.6

21.8

158

609

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.6

21.6

269

GAC10

NOMESCO Finland

Removal of foreign body from pleural cavity

115.4

21.6

L01BC06

ATC

capecitabine; oral

2.3

21.6

212

959

L04AA13

ATC

leflunomide; oral

2.9

21.6

135

475

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

2.1

21.5

250

1219

XX1XW

NOMESCO Finland

Extensive written report from radiologist

3.0

21.3

123

411

K78

ICPC

Atrial fibrillation/flutter

1.7

21.2

513

3210

L88

ICPC

Rheumatoid/seropositive arthritis

2.4

21.2

190

821

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.8

21.2

104

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

4.6

21.2

163

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.6

21.1

585

3796

C45.9

ICD-10 Finland

Mesothelioma, unspecified

50.2

21.1

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.0

21.0

292

1528

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

6.8

21.0

GD1AT

NOMESCO Finland

Biopsy of the lung with ultrasound guidance

7.1

21.0

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.1

21.0

115

372

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

21.0

884

6324

SPAT1255

SPAT

Intravenous administration of medicine

1.8

20.7

359

2032

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

77.1

20.7

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

12.9

20.6

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.4

20.6

100

296

TJA10

NOMESCO Finland

Laparocentesis

10.3

20.5

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.8

20.5

352

1985

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.9

20.5

314

1701

L03AA14

ATC

lipegfilgrastim; parenteral

3.4

20.5

102

307

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.9

20.4

311

1683

R53

ICD-10 Finland

Malaise and fatigue

1.4

20.4

990

7281

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

4.5

20.3

161

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

2.9

20.2

128

455

GAC47

NOMESCO Finland

Endoscopic partial decortication of pleura

32.6

20.2

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.7

20.2

144

550

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

2.1

20.1

242

1195

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.8

20.1

386

2262

TK810

NOMESCO Finland

Hemofiltration

5.4

20.0

112

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.1

19.7

230

1122

SPAT1056

SPAT

Pleural puncture

73.7

19.7

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.7

19.6

416

2507

TFP20

NOMESCO Finland

Cardiodefibrillation

1.7

19.6

454

2807

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

7.0

19.6

A79

ICPC

Malignancy NOS

3.3

19.6

100

308

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

2.3

19.5

190

855

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.6

19.5

553

3606

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.7

19.5

140

535

SPAT1062

SPAT

Lung clearance therapy

7.7

19.5

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.0

19.4

114

387

C34.80

ICD-10 Finland

Malignant overall tumor of bronchus and lung without histology

6.5

19.4

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

19.4

961

7085

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

19.3

500

3187

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

19.1

335

1905

SPAT1263

SPAT

Sampling

1.3

19.1

1986

16521

C01BD01

ATC

amiodarone; systemic

2.2

19.0

194

891

R09.1

ICD-10 Finland

Pleurisy

3.4

18.9

268

SPAT1262

SPAT

Handing over of treatment supplies

1.4

18.8

956

7077

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

18.8

208

994

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

3.5

18.8

259

JAH01

NOMESCO Finland

Laparoscopy

2.3

18.7

174

767

J01DA01

ATC

[U] cefalexin; systemic

1.3

18.6

3001

26448

JAH00

NOMESCO Finland

Laparotomy

2.4

18.6

162

693

127

Kela drug reimbursment

Transplant complication

3.6

18.5

236

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

2.8

18.3

121

442

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.3

18.2

1446

11538

S97

ICPC

Chronic ulcer skin

1.8

18.1

314

1779

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.6

18.1

135

H02AB04

ATC

methylprednisolone; systemic

1.5

18.0

655

4533

201

Kela drug reimbursment

Chronic cardiac insufficiency

1.7

17.9

357

2116

TGD00

NOMESCO Finland

Needle biopsy of lung

5.8

17.7

WX002

NOMESCO Finland

Sedation and analgesia

1.4

17.7

949

7089

L02BG06

ATC

exemestane; oral

4.0

17.7

180

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

17.6

1491

11999

L01EF01

ATC

palbociclib; oral

12.5

17.6

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.9

17.5

256

1366

A12AA04

ATC

calcium carbonate; oral

2.9

17.5

109

386

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.7

17.5

387

2365

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

3.0

17.4

101

341

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.6

17.3

494

3226

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.9

17.3

246

1300

C07AB02

ATC

metoprolol; systemic

1.3

17.2

1260

9914

A10AE05

ATC

insulin detemir; parenteral

1.9

17.2

277

1528

J43.9

ICD-10 Finland

Emphysema, unspecified

3.0

17.2

101

344

R03BA05

ATC

fluticasone; inhalant

1.5

17.2

720

5125

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.1

17.2

198

963

E0000UV

ATC

1.3

17.2

1698

13969

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.6

17.1

127

499

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

17.1

231

1199

A07AA09

ATC

vancomycin; oral

3.3

17.1

263

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

17.0

349

2085

I97.0

ICD-10 Finland

Postcardiotomy syndrome

5.8

17.0

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

4.7

16.9

122

J47

ICD-10 Finland

Bronchiectasis

2.9

16.9

105

371

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

3.6

16.9

213

GAA97

NOMESCO Finland

Other thoracoscopic drainage procedures on pleura

19.3

16.8

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

7.0

16.8

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

12.1

16.8

ZXA00

NOMESCO Finland

Right side

1.3

16.7

1378

11038

9053/3-C38.4

ICD-O-3

Mesothelioma, biphasic, malignant of pleura, NOS

+∞

16.7

R85

ICPC

Malignant neopl respiratory other

15.1

16.6

R06.2

ICD-10 Finland

Wheezing

2.1

16.5

181

863

R28

ICPC

Limited function/disability (R)

3.5

16.5

228

Angiography of the heart and coronary arteries

1.6

16.4

474

3106

C08CA01

ATC

amlodipine; oral

1.3

16.4

1952

16442

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.3

16.4

155

691

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.3

16.3

154

685

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

16.2

749

5435

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

3.0

16.2

302

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

2.0

16.2

204

1030

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

3.9

16.1

166

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.8

16.1

181

L01XE13

ATC

[U] afatinib; oral

30.1

16.1

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

16.0

416

2655

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.2

16.0

166

773

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

4.3

16.0

139

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.0

16.0

207

1058

GAC96

NOMESCO Finland

Other operation on pleura

21.0

15.9

TGE00

NOMESCO Finland

Needle biopsy of mediastinum

7.4

15.9

R11

ICD-10 Finland

Nausea and vomiting

1.7

15.8

348

2120

N17.8

ICD-10 Finland

Other acute renal failure

3.3

15.8

241

M13.9

ICD-10 Finland

Arthritis, unspecified

1.7

15.8

310

1826

J45.8

ICD-10 Finland

Mixed asthma

2.3

15.8

144

632

WW200

NOMESCO Finland

Immunization

2.4

15.8

137

585

9051/3-C38.4

ICD-O-3

Fibrous mesothelioma, malignant of pleura, NOS

60.1

15.7

V03AE01

ATC

polystyrene sulfonate; oral

2.9

15.7

319

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

15.7

842

6277

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

15.7

430

2780

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.0

15.7

314

51110

ICD-8 Finland

Pleurisy, With effusion, with mention of a bacterial cause other than tuberculosis

+∞

15.6

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.2

15.6

165

772

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

15.6

492

3292

N06AX11

ATC

mirtazapine; oral

1.3

15.6

1348

10849

3004

Kela drug reimbursment

Osimertinib

26.3

15.6

R60.0

ICD-10 Finland

Localized oedema

1.5

15.6

558

3844

GD1UN

NOMESCO Finland

Lung circulation SPECT

4.8

15.5

107

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.8

15.5

275

1572

C50.99

ICD-10 Finland

Breast, unspecified

2.6

15.4

112

436

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.4

15.4

128

534

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

3.8

15.3

174

XG460

NOMESCO Finland

Short time oxymetry

2.6

15.3

111

430

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

15.2

3224

29041

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.7

15.2

185

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

4.5

15.2

118

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

15.1

681

4911

R05

ICPC

Cough

1.4

15.1

882

6673

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

15.1

225

1212

A41.8

ICD-10 Finland

Other specified sepsis

2.6

15.0

109

422

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

15.0

266

1519

GD2SN

NOMESCO Finland

Lung ventilation SPECT

4.4

15.0

120

UJF32

NOMESCO Finland

Coloscopy

1.3

15.0

1264

10130

WX722

NOMESCO Finland

PEEP

1.9

14.9

231

1258

WX402

NOMESCO Finland

General anaesthesia

1.5

14.9

634

4522

WX730

NOMESCO Finland

Conventional respirator

2.9

14.9

324

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.6

14.9

112

443

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

5.9

14.9

A02BC05

ATC

esomeprazole; systemic

1.3

14.7

1818

15333

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

4.7

14.6

105

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

14.6

258

1471

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

+∞

14.6

5110B

ICD-9 Finland

Pleurisy, Without mention of effusion or current tuberculosis[PLEURA-ADHEESIOT]

+∞

14.6

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

7.7

14.6

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

2.3

14.5

135

598

WX110

NOMESCO Finland

Local anesthesy

1.2

14.5

2948

26355

A12BA01

ATC

potassium chloride; oral

1.7

14.5

302

1813

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.4

14.5

685

4986

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

2.2

14.5

150

698

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

3.1

14.4

264

P01AB01

ATC

metronidazole; oral, rectal

1.3

14.4

1605

13350

Z49.2

ICD-10 Finland

Other dialysis

4.6

14.4

107

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

3.9

14.4

149

137

Kela drug reimbursment

Uraemia requiring dialysis

3.8

14.4

159

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.2

14.4

139

628

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.8

14.3

258

1482

B03BA03

ATC

hydroxocobalamin; parenteral

1.7

14.3

328

2021

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.3

14.3

131

577

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

3.1

14.3

260

Z57.2

ICD-10 Finland

Occupational exposure to dust

11.3

14.2

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

11.3

14.2

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

8.2

14.2

J86.09

ICD-10 Finland

Pyothorax with fistula

19.1

14.2

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.6

14.2

407

2659

N19

ICD-10 Finland

Unspecified kidney failure

1.9

14.2

209

1121

J01MA02

ATC

ciprofloxacin; systemic

1.3

14.2

1987

17000

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

2.9

14.2

296

R04.0

ICD-10 Finland

Epistaxis

1.6

14.2

399

2597

D38.3

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Mediastinum

5.7

14.1

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.6

14.1

102

397

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

2.1

14.1

157

755

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

14.1

210

1131

L02BG03

ATC

anastrozole; oral

3.1

14.0

258

E87.5

ICD-10 Finland

Hyperkalaemia

2.5

14.0

110

447

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.3

14.0

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.7

13.9

306

1867

GDC00

NOMESCO Finland

Lobectomy of lung

4.0

13.8

140

R07.1

ICD-10 Finland

Chest pain on breathing

3.1

13.8

250

01220

ICD-8 Finland

Other respiratory tuberculosis, Pleurisy with effusion without mention of cause

7.8

13.8

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

4.4

13.8

112

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

13.8

361

2307

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

13.7

1459

12047

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

3.7

13.7

161

R03AC18

ATC

indacaterol; inhalant

3.7

13.7

156

ZX090

NOMESCO Finland

Other technic of radiotherapy

2.1

13.7

147

697

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

3.3

13.7

208

B01AF02

ATC

apixaban; oral

1.5

13.7

532

3726

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

13.6

298

1812

J01FA09

ATC

clarithromycin; systemic

1.3

13.6

1177

9449

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

13.6

1514

12576

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

13.6

656

4790

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

3.4

13.6

188

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

4.1

13.6

128

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.8

13.5

320

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

3.3

13.5

199

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.2

13.5

133

606

NHQ40

NOMESCO Finland

Amputation of toe

2.4

13.5

113

475

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

4.4

13.5

110

B03XA03

ATC

methoxy polyethylene glycol-epoetin beta; parenteral

4.5

13.4

106

J85.2

ICD-10 Finland

Abscess of lung without pneumonia

9.3

13.4

GDA10

NOMESCO Finland

Biopsy of lung

9.3

13.4

GCA98

NOMESCO Finland

Other bronchoscopic procedure on bronchus

4.4

13.4

111

WW200

SPAT

0.5

13.4

134

2451

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

2.2

13.3

129

584

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

13.3

1289

10504

I31.8

ICD-10 Finland

Other specified diseases of pericardium

11.5

13.3

HAC20

NOMESCO Finland

Total mastectomy

2.1

13.2

155

762

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

3.1

13.2

236

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

3.6

13.1

162

WX882

NOMESCO Finland

High dependency care

2.1

13.1

142

675

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

7.9

13.0

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

6.2

13.0

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

13.0

749

5644

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

2.4

12.9

106

440

SPAT1109

SPAT

Analgesia with portable analgesic pump

4.2

12.9

115

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

3.7

12.9

149

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

8.5

12.7

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

10.5

12.7

341

Kela drug reimbursment

Afatinib and gefitinib

32.1

12.6

B03XA01

ATC

erythropoietin; parenteral

3.3

12.5

195

A03

ICPC

Fever

1.5

12.5

482

3372

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

12.5

1407

11684

L01EB04

ATC

osimertinib; oral

24.3

12.4

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

3.7

12.4

144

SPAT1229

SPAT

Assessment of need for aid

1.5

12.4

412

2788

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.3

12.4

106

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

3.6

12.4

155

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

1.6

12.4

327

2095

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

2.3

12.3

115

513

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

1.6

12.3

285

1767

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

5.2

12.2

Z72.0

ICD-10 Finland

Tobacco use

2.4

12.2

103

438

A10AE04

ATC

insulin glargine; parenteral

1.5

12.2

453

3141

GEA00

NOMESCO Finland

Mediastinoscopy

5.7

12.2

SPAT1269

SPAT

Other puncture and/or drainage

3.9

12.2

127

M05BA04

ATC

alendronic acid; oral

1.5

12.1

378

2524

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.0

12.1

162

841

AA1

Conventional CABG

2.0

12.1

149

750

C07AA07

ATC

sotalol; systemic

1.7

12.1

256

1545

Z49.0

ICD-10 Finland

Preparatory care for dialysis

3.2

12.1

190

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

12.1

324

2085

ZXA05

NOMESCO Finland

Left side

1.3

12.0

1254

10298

1519

Kela drug reimbursment

21.3

12.0

JN6AD

NOMESCO Finland

CT of torso and neck

3.1

11.9

208

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

2.5

11.9

360

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

2.2

11.9

120

556

191

Kela drug reimbursment

Erlotinib

5.7

11.9

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.3

11.9

111

495

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

3.4

11.9

171

GDD20

NOMESCO Finland

Extended pneumonectomy

46.7

11.9

GAC40

NOMESCO Finland

Pleurodesis with decortication

46.7

11.9

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.9

11.8

182

993

M10.9

ICD-10 Finland

Gout, unspecified

1.5

11.7

367

2450

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

2.4

11.6

397

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

5.3

11.6

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

2.3

11.6

107

476

WX721

NOMESCO Finland

Oxygen concentrator therapy

22.9

11.5

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.1

11.5

125

598

A08

ICPC

Swelling

1.8

11.5

196

1109

J01XX08

ATC

linezolid; systemic

4.7

11.5

J98.5

ICD-10 Finland

Diseases of mediastinum, not elsewhere classified

+∞

11.5

J99.1*M31.3

ICD-10 Finland

Respiratory disorders in Wegener's granulomatosis

+∞

11.5

J91, I500

ICD-10 Finland

+∞

11.5

NK6AN

NOMESCO Finland

Total body bone isotope imaging

1.9

11.4

163

868

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

11.4

1637

13957

GEA20

NOMESCO Finland

Mediastinoscopy with excision of lesion

6.7

11.4

B05DA

ATC

Isotonic solutions

3.9

11.4

120

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

11.3

1031

8310

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

3.7

11.3

131

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

2.3

11.3

105

470

ZX100

NOMESCO Finland

Oral

2.6

11.3

304

K92.1

ICD-10 Finland

Melaena

1.6

11.2

290

1849

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.4

11.2

610

4550

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.2

11.2

114

530

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

4.6

11.2

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.4

11.1

387

XX1AW

NOMESCO Finland

Written report from X-ray examination without contrast peformed elsewhere

5.4

11.1

A02BC03

ATC

lansoprazole; oral

1.3

11.1

1352

11302

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.1

11.1

126

614

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.7

11.1

214

1256

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

1.9

11.1

162

869

Z94.0

ICD-10 Finland

Kidney transplant status

3.1

11.1

186

R03AK11

ATC

formoterol and fluticasone; inhalant

2.4

11.1

399

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.8

11.1

196

1122

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

11.0

1353

11324

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

3.0

11.0

213

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

11.0

1237

10242

GA2CT

NOMESCO Finland

Pleural biopsy with CT guidance

43.4

10.9

SPAT1211

SPAT

Application of soft bandage

1.5

10.8

392

2704

J20

ICD-10 Finland

Acute bronchitis

1.5

10.8

363

2464

M32.1

ICD-10 Finland

Systemic lupus erythematosus with organ or system involvement

15.5

10.8

L04AA01

ATC

[U] ciclosporin; systemic

2.7

10.8

276

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.2

10.8

106

485

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

10.6

10.7

R29

ICPC

Respiratory symptom/complaint other

1.7

10.7

241

1480

Coronary artery bypass surgery

1.8

10.7

178

1001

R06AE07

ATC

cetirizine; oral

1.2

10.7

1622

13895

SPAT1104

SPAT

Monitoring of emergency patient

1.6

10.6

301

1966

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

2.0

10.6

127

633

A16.0

ICD-10 Finland

Tuberculosis of lung, bacteriologically and histologically negative

7.5

10.6

N07BA03

ATC

varenicline; oral

1.9

10.6

150

795

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

10.6

419

2943

L04AD01

ATC

ciclosporin; systemic

2.6

10.6

290

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

2.7

10.6

273

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

8.0

10.6

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.0

10.5

128

643

XG405

NOMESCO Finland

Education on PEF monitoring

2.7

10.4

246

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.9

10.4

151

810

V03AE02

ATC

sevelamer; oral

4.6

10.4

51299

ICD-8 Finland

Spontaneous pneumothorax

+∞

10.4

J99.0*M05.1

ICD-10 Finland

Rheumatoid lung disease

+∞

10.4

L01XE06

ATC

[U] dasatinib; systemic

+∞

10.4

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

2.3

10.4

397

R03BB01

ATC

ipratropium bromide; inhalant

1.6

10.4

236

1457

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.0

10.4

123

613

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

2.7

10.3

257

XFE00

NOMESCO Finland

Epicardial ultrasonography

1.9

10.3

142

748

S18

ICPC

Laceration/cut

1.2

10.3

1971

17279

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

4.2

10.3

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

2.4

10.3

353

X76

ICPC

Malignant neoplasm breast female

2.7

10.3

259

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

10.3

161

888

M32.8

ICD-10 Finland

Other forms of systemic lupus erythematosus

8.8

10.2

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

3.9

10.2

107

S27.1

ICD-10 Finland

Traumatic haemothorax

3.7

10.2

117

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

3.0

10.2

192

N05BA01

ATC

diazepam; systemic, rectal

1.4

10.2

573

4297

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

4.9

10.2

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

4.3

10.1

M01CB01

ATC

sodium aurothiomalate; parenteral

2.5

10.1

323

A04

ICPC

Weakness/tiredness general

1.4

10.1

554

4131

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.9

10.1

146

781

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.7

10.1

189

1101

N06AB04

ATC

citalopram; systemic

1.3

10.1

866

6915

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

5.9

10.1

R03AC19

ATC

olodaterol; inhalant

4.7

10.1

T81.7

ICD-10 Finland

Vascular complications following a procedure, not elsewhere classified

5.6

10.1

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

10.0

1754

15232

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.6

10.0

289

1896

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.6

10.0

264

1693

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.7

10.0

209

1262

GDA96

NOMESCO Finland

Other incision, excision of lesion or repair of lung

40.1

10.0

N05CD07

ATC

temazepam; oral

1.3

9.9

680

5256

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

4.2

9.9

T36

ICD-10 Finland

Poisoning by systemic antibiotics

1.9

9.9

132

686

ZX112

NOMESCO Finland

Subcutaneous

2.1

9.9

112

547

TJA40

NOMESCO Finland

Percutaneous local drainage of peritoneal cavity

16.7

9.9

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

3.1

9.9

169

A07AA02

ATC

nystatin; oral

1.6

9.8

276

1800

J18

ICD-10 Finland

Pneumonia, organism unspecified

3.3

9.8

148

Z50.0

ICD-10 Finland

Cardiac rehabilitation

2.4

9.8

336

R03BA08

ATC

ciclesonide; inhalant

1.6

9.8

265

1713

R77.0

ICD-10 Finland

Abnormality of albumin

8.7

9.8

R03AC13

ATC

formoterol; inhalant

1.7

9.7

211

1289

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.6

9.6

222

1378

E86

ICD-10 Finland

Volume depletion

1.9

9.6

136

725

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

2.8

9.6

223

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.0

9.5

117

592

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

1.7

9.5

184

1085

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

9.5

264

1715

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

2.4

9.5

327

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

3.4

9.5

130

WX204

NOMESCO Finland

Axillary plexus blockaced

2.0

9.5

123

635

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.1

9.5

157

20199

ICD-8 Finland

Hodgkin's disease

15.0

9.5

N03AG01

ATC

valproic acid; systemic, rectal

1.6

9.5

219

1360

ZX121

NOMESCO Finland

Central venous catheter

5.4

9.5

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

2.3

9.4

389

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

3.0

9.4

183

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

2.2

9.4

390

GDD96

NOMESCO Finland

Other pneumonectomy

100.2

9.4

150

Kela drug reimbursment

Dasatinib

100.2

9.4

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

3.3

9.4

142

FE2AT

NOMESCO Finland

Pericardial cathetrisation with ultrasound guidance

30.0

9.4

ZST00

NOMESCO Finland

Procedure related to previous procedure classified in chapter T

7.5

9.4

C45.1

ICD-10 Finland

Mesothelioma of peritoneum

17.5

9.4

J94.1

ICD-10 Finland

Fibrothorax

+∞

9.4

C45

ICD-10 Finland

Mesothelioma

+∞

9.4

RS220

NOMESCO Finland

2.8

9.4

204

1510

Kela drug reimbursment

Niraparib

21.7

9.3

3009

Kela drug reimbursment

Niraparib

21.7

9.3

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

9.3

130

690

L01XE03

ATC

[U] erlotinib; oral

5.5

9.3

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

2.3

9.3

346

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

2.4

9.2

309

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

9.2

268

1760

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

9.2

271

1787

K65.0

ICD-10 Finland

Acute peritonitis

2.5

9.2

284

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.5

9.2

268

1765

1CD01

NOMESCO Finland

7.3

9.2

PG5DE

NOMESCO Finland

Ultrasound examination of injection gate to artery or vein with Doppler method

5.4

9.2

N02AA03

ATC

hydromorphone; systemic, rectal

5.7

9.2

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.2

9.2

414

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.8

9.1

140

768

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

3.0

9.1

162

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

4.9

9.1

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.1

9.1

441

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.5

9.0

281

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.4

9.0

120

I20.09

ICD-10 Finland

Unstable angina

1.5

9.0

322

2218

196

Kela drug reimbursment

Paricalcitol and cinacalcet

4.4

9.0

B05DB

ATC

Hypertonic solutions

3.7

9.0

100

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.4

9.0

364

2573

N07BB01

ATC

disulfiram; oral

1.8

9.0

146

817

J15.8

ICD-10 Finland

Other bacterial pneumonia

3.1

8.9

148

Z94.2

ICD-10 Finland

Lung transplant status

18.6

8.9

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.3

8.9

322

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

6.1

8.9

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

3.9

8.9

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

5.5

8.9

XF404

NOMESCO Finland

Ambulatory ECG

1.4

8.8

448

3296

SPAT1216

SPAT

Assessment of functional ability

1.3

8.8

767

6128

J70.0

ICD-10 Finland

Acute pulmonary manifestations due to radiation

6.8

8.8

WX600

NOMESCO Finland

Single shot through catheter

2.7

8.8

212

SPAT1060

SPAT

Administration of oxygen

4.0

8.8

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

2.9

8.8

177

GD2AT

NOMESCO Finland

Cytology of the lungs with ultrasound guidance

6.3

8.8

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

3.0

8.7

170

XF622

NOMESCO Finland

Measurement of minute volume of heart

5.3

8.7

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

2.9

8.7

171

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

3.4

8.6

114

N05AH03

ATC

olanzapine; systemic

1.7

8.6

180

1088

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

8.5

719

5722

E87.6

ICD-10 Finland

Hypokalaemia

1.9

8.5

125

676

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.2

8.5

361

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

3.2

8.5

137

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

8.5

295

2020

WD515

NOMESCO Finland

Demanding therapy of malignancy with enzyme inhibitors and similar treatments

4.9

8.5

NDG30

NOMESCO Finland

Fusion of wrist, total

4.5

8.4

PB1DE

NOMESCO Finland

Upper extremity arteries ultrasound examination with Doppler method

5.1

8.4

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

2.5

8.4

241

TPH05

NOMESCO Finland

Open cannulation of peripheral vein

2.8

8.4

184

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

2.3

8.4

326

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

8.4

276

1868

51109

ICD-8 Finland

Pleurisy, Sicca NUD

+∞

8.3

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.4

8.3

387

2806

A41.1

ICD-10 Finland

Sepsis due to other specified staphylococcus

3.1

8.3

134

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

2.9

8.3

166

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.0

8.3

490

197

Kela drug reimbursment

Sunitinib

4.3

8.3

R03BB07

ATC

umeclidinium bromide; inhalant

3.2

8.3

129

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

3.1

8.3

140

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

2.4

8.3

290

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

3.4

8.2

108

R03BA01

ATC

beclometasone; inhalant

1.3

8.2

547

4211

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

8.2

1307

11206

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.7

8.2

174

1057

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

5.1

8.1

TJD20

NOMESCO Finland

Change of gastrostomy tube

5.1

8.1

V03AE03

ATC

lanthanum carbonate; oral

5.1

8.1

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

2.7

8.1

199

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

3.9

8.1

C38.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of heart, mediastinum and pleura

33.4

8.1

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.0

8.1

480

SPAT1231

SPAT

Assessment of adjustments needed in living environment

1.9

8.0

105

546

L01XE04

ATC

[U] sunitinib; oral

4.8

8.0

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

2.0

8.0

482

8070/3-C34.3

ICD-O-3

Squamous cell carcinoma, NOS, of lower lobe, lung

4.0

8.0

I31.1

ICD-10 Finland

Chronic constrictive pericarditis

10.0

8.0

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

1.9

8.0

115

619

L01XK02

ATC

niraparib; oral

22.0

8.0

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

1.6

8.0

189

1183

FWW96

NOMESCO Finland

Other reoperation on heart or major thoracic vessels

5.8

8.0

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

4.0

7.9

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

2.5

7.9

246

H3603, E103

ICD-10 Finland

3.1

7.9

128

I51.4

ICD-10 Finland

Myocarditis, unspecified

4.4

7.9

TK820

NOMESCO Finland

Peritoneal dialysis

4.4

7.9

ZPB40

NOMESCO Finland

Polytetrafluoroethylene

3.7

7.9

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

2.6

7.9

214

3AC01

NOMESCO Finland

2.7

7.9

197

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.9

2938

27129

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

3.4

7.9

107

A99

ICPC

Disease/condition unspecnature/site

1.4

7.9

330

2351

R03BA02

ATC

budesonide; inhalant

1.3

7.9

653

5183

GDB10

NOMESCO Finland

Wedge resection of lung

7.7

7.9

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

2.6

7.8

216

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

2.0

7.8

459

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

3.7

7.8

A01AB09

ATC

miconazole; local oral

1.4

7.8

366

2661

WX130

NOMESCO Finland

Interpleural anesthesia

8.4

7.8

A02BA02

ATC

ranitidine; systemic

1.2

7.8

943

7844

TK830

NOMESCO Finland

Ultrafiltration

10.8

7.8

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.2

7.8

344

I12.0

ICD-10 Finland

Hypertensive renal disease with renal failure

2.4

7.8

254

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

2.4

7.8

273

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

7.7

236

1573

103

Kela drug reimbursment

Diabetes, insulin-treated

1.2

7.7

1394

12083

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

3.7

7.7

PH1YT

NOMESCO Finland

Endovascular insertion of stent to veins of upper extremity or to superior vena cava

45.0

7.7

L01XE35

ATC

[U] osimertinib; oral

45.0

7.7

Y60.6

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during aspiration, puncture and other catheterization

15.0

7.7

D07AC01

ATC

betamethasone; topical

1.2

7.7

1477

12875

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

7.7

633

5018

A10BB12

ATC

glimepiride; oral

1.4

7.7

419

3122

ZX070

NOMESCO Finland

Intensity modified radiotherapy

2.0

7.7

493

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

3.0

7.7

137

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1.8

7.6

127

717

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

4.1

7.6

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

2.3

7.6

288

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

7.6

215

1406

L01XE02

ATC

[U] gefitinib; oral

18.4

7.6

C08DB01

ATC

diltiazem; oral

1.4

7.6

308

2182

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.0

7.6

450

GDG10

NOMESCO Finland

Bilateral transplantation of lung

25.0

7.6

GX2C5

NOMESCO Finland

Short-lasting oximetry

11.8

7.6

ZXD00

NOMESCO Finland

Emergency procedure

1.7

7.6

139

811

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.2

7.5

1382

11992

R4180

NOMESCO Finland

Podiatric therapy

2.7

7.5

176

J98.4

ICD-10 Finland

Other disorders of lung

10.0

7.5

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.5

7.5

241

1624

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.4

7.5

253

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.0

7.5

427

N05AH02

ATC

clozapine; systemic

2.5

7.5

209

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

1.9

7.5

109

592

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.2

7.5

305

Z3229

NOMESCO Finland

Other healthcare associate professional

1.4

7.5

384

2839

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

2.9

7.4

140

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

2.7

7.4

169

8000/3-C38.4

ICD-O-3

Neoplasm, malignant of pleura, NOS

80.2

7.4

K56.7

ICD-10 Finland

Ileus, unspecified

2.0

7.4

436

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

6.4

7.4

J85.1

ICD-10 Finland

Abscess of lung with pneumonia

6.4

7.4

A15.1

ICD-10 Finland

Tuberculosis of lung, confirmed by culture only

6.4

7.4

ZX108

NOMESCO Finland

Inhalation

3.3

7.4

102

C02AC05

ATC

moxonidine; oral

1.5

7.4

211

1387

AB2

AVR bio, stent

2.5

7.4

212

R5140

NOMESCO Finland

Monitoring the use of the aid

1.4

7.4

413

3096

R52.0

ICD-10 Finland

Acute pain

1.9

7.4

104

559

R03DA04

ATC

theophylline; systemic, rectal

1.4

7.4

284

1991

WX250

NOMESCO Finland

Intercostal blockade

6.0

7.4

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

2.7

7.4

181

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

0.4

7.4

640

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

1.5

7.3

218

1444

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

2.5

7.3

206

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

7.3

593

4695

SPAT1251

SPAT

Organisation of medication

1.6

7.3

177

1116

C48.89

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor

8.3

7.3

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

7.3

318

2279

GAC34

NOMESCO Finland

Endoscopic mechanical pleurodesis

+∞

7.3

J99.0

ICD-10 Finland

Rheumatoid lung disease

+∞

7.3

PBL09

NOMESCO Finland

Construction of arteriovenous fistula from brachial artery

4.5

7.2

C80.90

ICD-10 Finland

Malignant tumor without specified localization without histology

5.1

7.2

WX726

NOMESCO Finland

High-flow oxygen therapy

15.7

7.2

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.3

7.2

466

3568

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

2.8

7.2

154

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

2.6

7.2

184

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

3.0

7.2

132

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

1.9

7.2

521

169

Kela drug reimbursment

Crizotinib

30.0

7.1

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

2.3

7.1

279

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.9

7.1

522

3A064

NOMESCO Finland

3.8

7.1

5861

FHL

Pleural biopsy or removal of local change

20.0

7.1

A12AA12

ATC

[U] calcium acetate anhydrous; systemic

4.8

7.1

I71.4

ICD-10 Finland

Abdominal aortic aneurysm, without mention of rupture

1.6

7.1

162

1007

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

3.2

7.1

111

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.1

7.1

335

N05AH04

ATC

quetiapine; oral

1.3

7.0

535

4194

AN2

Balloon angioplasty, including several vessels

1.6

7.0

153

937

GWE00

NOMESCO Finland

Reoperation for deep haemorrhage in thoracic surgery

8.8

7.0

PG5AC

NOMESCO Finland

Contrast examination of injection gate to artery or vein

8.8

7.0

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

2.6

7.0

181

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.7

7.0

129

755

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

10.0

7.0

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

4.3

7.0

C34.86

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary microcellular carcinoma

4.7

7.0

FB1AD

NOMESCO Finland

CT examination of arteria pulmonalis

3.3

7.0

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.8

7.0

145

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.6

7.0

192

I27.9

ICD-10 Finland

Pulmonary heart disease, unspecified

3.4

7.0

UJF92

NOMESCO Finland

Capsular endoscopy

2.1

7.0

342

SPAT1139

SPAT

Nutrition survey

1.7

7.0

132

780

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

2.9

7.0

138

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

7.0

354

2613

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

1.8

6.9

112

630

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

3.0

6.9

124

I26

ICD-10 Finland

Pulmonary embolism

2.8

6.9

146

Z29.0

ICD-10 Finland

Isolation

3.6

6.9

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

2.2

6.9

289

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.3

6.9

410

3100

K86.1

ICD-10 Finland

Other chronic pancreatitis

2.6

6.9

183

SPAT1301

SPAT

No procedures

1.2

6.9

1436

12589

M31.3

ICD-10 Finland

Wegener granulomatosis

5.1

6.9

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

5.8

6.9

I30.0

ICD-10 Finland

Acute nonspecific idiopathic pericarditis

7.5

6.9

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

2.1

6.9

371

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.3

6.9

477

3694

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

2.5

6.9

202

C34.36

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma

4.6

6.9

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

4.6

6.9

I44.2

ICD-10 Finland

Atrioventricular block, complete

1.6

6.9

150

924

LCD00

NOMESCO Finland

Hysterectomy

1.7

6.9

126

739

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

3.5

6.8

L01CB01

ATC

etoposide; systemic

3.5

6.8

R07.3

ICD-10 Finland

Other chest pain

1.4

6.8

380

2845

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

2.1

6.8

373

C08DA01

ATC

verapamil; systemic

1.5

6.8

194

1274

SPAT1234

SPAT

Support of social functional capacity

1.5

6.8

234

1601

8140/3-C80.9

ICD-O-3

Adenocarcinoma, NOS, of unknown primary site

4.8

6.8

S22.4

ICD-10 Finland

Multiple fractures of ribs

1.9

6.8

523

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.6

6.8

167

1058

PF1AT

NOMESCO Finland

Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)

2.4

6.8

215

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

5.0

6.8

K70.9

ICD-10 Finland

Alcoholic liver disease, unspecified

4.1

6.8

G62.1

ICD-10 Finland

Alcoholic polyneuropathy

4.1

6.8

I20.00

ICD-10 Finland

Unstable angina

1.6

6.8

184

1195

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.8

6.8

110

618

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

6.8

443

NHG76

NOMESCO Finland

Arthroplasty of other tarsometatarsal joint

2.3

6.8

266

TPX15

NOMESCO Finland

Removal of vascular injection port

4.0

6.8

GDW96

NOMESCO Finland

Other operation on lung

40.1

6.8

FEF10

NOMESCO Finland

Subtotal pericardiectomy

40.1

6.8

NA2AD

NOMESCO Finland

Thoracic spine CT examination

3.6

6.7

I40.9

ICD-10 Finland

Acute myocarditis, unspecified

3.6

6.7

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.2

6.7

275

PE1AT

NOMESCO Finland

Femoral artery PTA

2.2

6.7

308

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.6

6.7

157

984

R60.9

ICD-10 Finland

Oedema, unspecified

1.5

6.7

193

1271

JBA10

NOMESCO Finland

Transabdominal biopsy or excision of lesion of diaphragm

16.7

6.7

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

2.3

6.7

267

D72.8

ICD-10 Finland

Other specified disorders of white blood cells

2.6

6.7

174

1XC07

NOMESCO Finland

4.7

6.7

RJ120

NOMESCO Finland

7.2

6.7

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.6

6.7

184

B01AC04

ATC

clopidogrel; oral

1.2

6.7

876

7340

N18.5

ICD-10 Finland

Chronic kidney disease, stage 5

4.1

6.7

3001

Kela drug reimbursment

Alectinib

22.5

6.7

J86

ICD-10 Finland

Pyothorax

22.5

6.7

1504

Kela drug reimbursment

Alectinib

22.5

6.7

1CD02

NOMESCO Finland

3.1

6.7

111

SPAT1260

SPAT

Consultation of another employee

1.2

6.6

747

6158

I47.2

ICD-10 Finland

Ventricular tachycardia

1.8

6.6

109

616

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

4.4

6.6

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

2.6

6.6

169

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

3.1

6.6

106

159

Kela drug reimbursment

Pazopanib

5.1

6.6

Z94.1

ICD-10 Finland

Heart transplant status

5.1

6.6

AS4

Physiological pacemaker insertion DDD (R)

2.0

6.6

401

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

5.9

6.6

D72.1

ICD-10 Finland

Eosinophilia

4.2

6.6

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

1.9

6.6

471

RS221

NOMESCO Finland

2.2

6.6

264

M35.1

ICD-10 Finland

Other overlap syndromes

3.9

6.5

JAL00

NOMESCO Finland

Biopsy of peritoneum

3.7

6.5

K56.0

ICD-10 Finland

Paralytic ileus

2.3

6.5

253

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.6

6.5

180

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

2.8

6.5

134

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.7

6.5

133

805

GBB00

NOMESCO Finland

Tracheostomy

2.3

6.5

246

EB1WA

NOMESCO Finland

3.1

6.5

102

J01FA15

ATC

telithromycin; oral

1.4

6.5

327

2407

ZZA00

NOMESCO Finland

Split skin graft

1.6

6.5

141

866

M01AH02

ATC

rofecoxib; oral

1.3

6.5

579

4638

H3603, E113

ICD-10 Finland

2.4

6.5

208

N05AF03

ATC

chlorprothixene; systemic

2.0

6.5

423

L82

ICD-10 Finland

Seborrhoeic keratosis

0.8

6.5

404

5160

J02AC01

ATC

fluconazole; systemic

1.2

6.5

1258

10954

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

1.7

6.5

136

829

V03AA01

ATC

2.0

6.5

361

QD6S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in foot

5.3

6.4

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

1.7

6.4

127

761

R13

ICD-10 Finland

Dysphagia

1.4

6.4

273

1950

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

2.3

6.4

229

J92

ICD-10 Finland

Pleural plaque

69.9

6.4

L01XE16

ATC

[U] crizotinib; oral

69.9

6.4

N06AX16

ATC

venlafaxine; oral

1.3

6.4

381

2885

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

2.7

6.4

143

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.4

6.4

285

2053

GD2FN

NOMESCO Finland

Lung ventilation distribution isotope examination (radiospirometry)

14.3

6.4

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

1.7

6.4

116

679

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

6.3

196

1315

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

6.3

117

685

RD210

NOMESCO Finland

2.2

6.3

284

R55

ICD-10 Finland

Syncope and collapse

1.3

6.3

527

4188

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

2.0

6.3

345

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

2.6

6.3

162

JFB30

NOMESCO Finland

Right hemicolectomy

2.0

6.3

385

9284

FHL

Wrist ossification surgery

5.9

6.3

D638, N188

ICD-10 Finland

9.2

6.3

R05FB02

ATC

cough suppressants and expectorants

1.2

6.3

1716

15371

GD1AA

SPAT

1.6

6.3

163

1052

KAC10

NOMESCO Finland

Total nephrectomy with capsule

2.4

6.2

199

8041/3-C34.9

ICD-O-3

Small cell carcinoma, NOS, of lung, NOS

2.6

6.2

156

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

2.0

6.2

361

J99.1

ICD-10 Finland

Respiratory disorders in other diffuse connective tissue disorders

+∞

6.2

5120A

ICD-9 Finland

Pneumothorax, Spontaneous tension pneumothorax

+∞

6.2

D69.6

ICD-10 Finland

Thrombocytopenia, unspecified

1.9

6.2

443

K72.9

ICD-10 Finland

Hepatic failure, unspecified

3.1

6.2

100

GWW96

NOMESCO Finland

Other reoperation in thoracic surgery

26.7

6.2

GAW97

NOMESCO Finland

Other thoracoscopic operation on chest wall, pleura and diaphragm

26.7

6.2

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.0

6.2

352

N17.0

ICD-10 Finland

Acute renal failure with tubular necrosis

2.7

6.2

140

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

4.3

6.2

JA3BT

NOMESCO Finland

Cathetrisation of abdominal cavity with X-ray guidance

4.3

6.2

8000/3-C34.1

ICD-O-3

Neoplasm, malignant of upper lobe, lung

4.3

6.2

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

4.3

6.2

E10

ICD-10 Finland

Type 1 diabetes mellitus

2.3

6.2

239

C34.35

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma

7.0

6.2

293

Kela drug reimbursment

Baricitinib

7.0

6.2

3006

Kela drug reimbursment

Baricitinib

7.0

6.2

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

6.2

406

3122

J46

ICD-10 Finland

Status asthmaticus

1.8

6.2

535

T90

ICPC

Diabetes non-insulin dependent

1.2

6.2

1090

9404

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.1

6.2

306

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

2.6

6.2

158

Z94.4

ICD-10 Finland

Liver transplant status

5.0

6.2

I49.5

ICD-10 Finland

Sick sinus syndrome

1.5

6.2

197

1333

Y84.8

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

6.2

101

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.5

6.1

204

1390

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.4

6.1

280

2032

ZXE90

NOMESCO Finland

More than 22 hours

2.4

6.1

203

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

2.3

6.1

234

R60.1

ICD-10 Finland

Generalized oedema

3.4

6.1

R63.4

ICD-10 Finland

Abnormal weight loss

1.6

6.1

147

932

Catheterization and pressure measurement of the right side of the heart

3.2

6.1

168

Kela drug reimbursment

Axitinib

12.5

6.1

E13.9

ICD-10 Finland

Other specified diabetes mellitus, without complications

2.5

6.1

178

AP3

Catheterization of the right and left side of the heart

4.0

6.1

J37.0

ICD-10 Finland

Chronic laryngitis

1.7

6.1

115

683

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

1.7

6.1

115

683

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

3.7

6.1

Z51.88

ICD-10 Finland

Other specified medical care

1.9

6.0

459

WX213

NOMESCO Finland

Lower leg blockade

2.7

6.0

143

M01AX17

ATC

nimesulide; oral

1.2

6.0

1082

9347

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.6

6.0

165

1075

C92.1

ICD-10 Finland

Chronic myeloid leukaemia [CML], BCR/ABL-positive

4.9

6.0

-1

NOMESCO Finland

1.2

6.0

1126

9763

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

3.3

6.0

D47.2

ICD-10 Finland

Monoclonal gammopathy of undetermined significance (MGUS)

2.1

6.0

281

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3014891) Appearance of Pleural fluid

201

36.39

322.10

1.9

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

204

32.40

316.02

1.4

1.2

mmol/l

1.8

1.3

1.59

173

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

168

71.88

310.62

1.2

1.1

u/l

17.3

15.2

0.27

126

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1548

5807

3.21

310.23

3.4

4.1

ug/l

16.8

19.6

0.29

1297

4824

(3023368) Bacteria identified in Blood by Culture

3144

15871

2.95

307.65

6.3

4.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

381

55.47

307.65

1.6

1.2

19.3

23.5

0.62

336

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1280

961

16.45

307.65

1.9

1.3

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

1531

286

70.31

307.65

1.5

1.2

u/l

398.3

324.3

0.99

1478

266

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

995

1421

8.12

307.65

1.8

1.6

—

(3011544) Albumin [Mass/volume] in Pleural fluid

180

92.61

307.65

1.2

1.1

g/l

18.7

12.6

2.59

174

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

607

129

51.94

307.65

1.6

1.2

64.7

61.4

0.45

522

(3020630) Protein [Mass/volume] in Serum or Plasma

2093

4636

6.25

307.65

2.4

2.5

g/l

64.2

66.3

22.31

2011

4112

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

622

127.64

307.65

1.4

1.1

ug/l

193.0

634.3

0.39

351

(3023383) Lactate [Moles/volume] in Pleural fluid

550

74.27

307.65

1.4

1.3

mmol/l

3.7

3.5

0.19

511

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

1367

181

96.08

307.65

1.4

1.1

u/l

14.3

13.0

0.34

1320

153

(44786800) Granulocytes/100 leukocytes in Body fluid

278

103.80

307.65

1.4

1.3

22.6

18.7

0.30

228

(3042631) Mycobacterium sp identified in Specimen

565

658

9.33

307.65

2.5

2.6

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

249

58.87

307.65

1.6

1.2

10.0

11.1

0.11

150

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1485

1689

11.18

307.65

2.5

2.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

1624

387

56.12

307.65

1.7

1.3

e6/l

67522.1

25447.1

4.82

1063

204

(3000919) Neutrophils/100 leukocytes in Pleural fluid

469

55.59

307.65

1.5

1.2

18.2

28.5

2.52

438

(3012441) Differential panel - Pleural fluid

1602

347

61.49

307.65

1.7

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

1375

310

56.40

307.65

1.5

1.2

mmol/l

5.9

7.1

6.95

1297

282

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

1199

189

78.05

307.65

1.5

1.3

u/l

12.6

14.1

1.64

1170

177

(3042936) Bacteria identified in Isolate by Culture

2447

7200

4.91

307.65

2.5

2.0

—

(3023199) Leukocytes [#/volume] in Pleural fluid

1724

435

54.11

307.65

1.7

1.2

e6/l

2496.5

2396.3

0.05

1322

285

(3035880) pH of Pleural fluid

890

172

60.06

307.65

1.4

1.2

—

(40768806) Pleura Pathology biopsy report

1669

327

68.98

307.65

1.9

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

2044

473

63.37

307.65

1.7

1.2

g/l

36.2

28.4

29.88

1931

392

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2222

6470

4.75

307.65

3.8

4.0

u/l

237.7

246.2

1.59

2164

6047

(3001893) Eosinophils/100 leukocytes in Pleural fluid

535

62.75

307.65

1.6

1.3

2.9

2.4

0.25

471

(3045788) Cell count panel - Pleural fluid

1214

356

41.97

307.65

1.8

1.3

—

(42870588) Differential panel, method unspecified - Blood

3082

16697

2.65

307.41

8.5

5.4

—

(3022096) Basophils/100 leukocytes in Blood

3680

21768

2.65

305.48

8.9

5.6

0.6

0.7

7.34

3546

20037

(3019069) Monocytes/100 leukocytes in Blood

3745

22483

2.63

299.16

9.3

6.0

9.2

8.9

5.22

3609

20730

(3006504) Eosinophils/100 leukocytes in Blood

3733

22381

2.63

298.96

8.9

5.6

2.6

2.9

15.41

3602

20560

(3001604) Monocytes [#/volume] in Blood

3866

23734

2.62

292.01

8.5

5.3

e9/l

0.7

0.6

20.35

3409

20072

(3006315) Basophils [#/volume] in Blood

3881

23896

2.62

290.92

8.5

5.4

e9/l

0.0

0.83

3430

20242

(3002030) Lymphocytes/100 leukocytes in Blood

3766

22919

2.59

288.31

9.1

5.8

21.4

26.4

128.30

3622

20986

(3019198) Lymphocytes [#/volume] in Blood

3906

24336

2.58

282.06

8.7

5.5

e9/l

1.6

1.9

10.86

3496

20933

(3013115) Eosinophils [#/volume] in Blood

3936

24642

2.58

280.81

9.0

5.5

e9/l

0.2

2.47

3512

21137

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

156

49.96

270.11

1.6

1.3

73.5

80.9

0.93

136

(3042010) Triglyceride [Moles/volume] in Pleural fluid

165

36.80

265.41

1.4

1.2

mmol/l

1.0

2.7

0.46

135

(3018010) Neutrophils/100 leukocytes in Blood

3651

22593

2.46

258.77

8.7

5.6

62.8

58.3

86.36

3509

20816

(3014111) Lactate [Moles/volume] in Serum or Plasma

1311

4921

3.10

257.94

6.9

6.2

mmol/l

1.3

1.4

1.31

1251

4698

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1865

8469

2.70

257.16

5.2

3.0

mmol/l

0.8

3.71

1771

7821

(3032080) INR in Blood by Coagulation assay

3687

22989

2.45

255.84

15.7

10.8

inr

1.4

0.36

1070

6215

(3013650) Neutrophils [#/volume] in Blood by Automated count

4195

27794

2.51

253.27

16.2

8.3

e9/l

4.7

4.3

15.63

3801

23930

(4035726)

1196

4342

3.16

248.51

1.5

1.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

152

37.96

246.59

1.4

1.3

u/l

91.5

1176.3

0.52

128

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3017

17590

2.37

238.37

4.5

3.1

ng/l

2886.9

1796.7

13.97

2753

15161

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4020

26656

2.39

233.71

10.8

6.0

umol/l

11.7

12.4

2.16

3889

25205

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

415

714

6.15

231.69

1.6

1.9

ug/l

20.4

23.5

0.58

403

699

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1893

9230

2.50

220.00

2.3

1.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

3548

23017

2.23

206.81

7.7

4.7

g/l

31.6

34.8

156.62

3358

21167

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

763

2382

3.51

200.33

2.3

1.8

ug/l

3.7

2.7

0.25

706

2073

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

362

629

6.04

199.71

1.2

1.1

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1752

8623

2.43

196.05

2.8

1.9

31.2

30.2

6.60

1701

8367

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

449

983

4.84

191.39

1.6

—

(1616796) Gas panel - Central venous blood

487

1162

4.46

186.47

5.0

3.1

—

(3037522) Nuclear Ab [Titer] in Serum

1240

5314

2.66

184.94

1.5

1.3

titre

514.0

498.5

0.12

301

1129

(3009445) Proteinase 3 Ab [Units/volume] in Serum

685

2113

3.51

182.58

1.5

1.4

u/ml

27.0

12.3

0.61

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

679

2118

3.47

177.70

3.3

2.8

u/ml

0.3

0.73

379

1205

(3009343) pH of Capillary blood

920

3451

2.95

176.42

5.4

3.2

7.4

0.08

151

398

(3020779) Urea [Moles/volume] in Serum or Plasma

1208

5226

2.62

175.98

11.2

6.4

mmol/l

12.4

11.0

6.43

1144

4922

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

928

3505

2.93

175.70

5.4

3.2

kpa

5.3

5.1

11.64

880

3178

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

478

1177

4.31

175.50

2.1

1.4

g/l

1.0

1.2

10.78

456

1114

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

468

1136

4.37

175.06

2.0

1.4

g/l

0.2

0.03

449

1077

(3044416) Complement C4 [Mass/volume] in Pleural fluid

73.38

174.14

1.2

1.1

g/l

0.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

893

3326

2.96

173.28

5.3

3.1

mmol/l

2.7

1.5

14.85

727

2352

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1547

7673

2.35

166.36

3.5

2.6

19.6

22.2

11.62

1357

6427

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3521

24121

2.04

161.67

10.3

5.8

mmol/l

1.2

14.80

3303

21587

(3022948) Iron [Moles/volume] in Serum or Plasma

1688

8790

2.26

161.00

3.4

2.5

umol/l

10.2

12.4

35.39

1570

8055

(3027315) Oxygen [Partial pressure] in Blood

451

1141

4.18

159.45

6.5

3.5

kpa

8.2

8.5

2.68

444

1114

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1602

8192

2.28

159.43

3.4

2.5

g/l

2.1

2.3

13.40

1494

7509

(3013290) Carbon dioxide [Partial pressure] in Blood

449

1135

4.18

158.91

6.5

3.4

kpa

5.1

4.9

7.23

442

1109

(3012501) Base excess in Blood by calculation

449

1135

4.18

158.91

6.5

3.4

mmol/l

3.2

2.4

6.83

353

746

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

826

3085

2.93

158.74

8.3

6.3

mmol/l

25.4

24.6

7.17

820

3058

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1350

6440

2.39

157.74

8.7

6.4

kpa

5.2

5.0

9.44

1289

6101

(3027801) Oxygen [Partial pressure] in Arterial blood

1347

6438

2.39

156.59

8.7

6.4

kpa

11.0

12.1

14.67

1287

6090

(3003396) Base excess in Arterial blood by calculation

1341

6416

2.38

155.40

8.7

6.4

mmol/l

1.8

0.8

12.54

1116

4878

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

447

1145

4.12

155.34

1.7

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1435

7096

2.32

153.95

9.2

5.6

mmol/l

1.1

1.0

11.27

1344

6506

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3760

26645

2.01

153.63

11.9

6.5

mmol/l

1.2

15.82

3129

22323

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1325

6382

2.36

150.74

2.2

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

431

1101

4.13

150.25

1.7

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1323

6406

2.35

148.46

2.2

1.7

—

(3010421) pH of Blood

477

1329

3.80

147.21

6.5

3.4

7.4

0.10

443

1112

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

362

845

4.48

141.93

1.7

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

412

1091

3.97

136.49

1.6

1.8

mg/l

10.3

12.5

3.03

392

993

(3005719) IgG [Mass/volume] in Serum or Plasma

814

3270

2.71

135.16

3.0

2.6

g/l

10.7

10.6

0.17

747

2957

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

346

825

4.38

131.90

1.6

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

519

1642

3.35

131.63

1.7

1.5

titre

345.3

229.6

0.35

(3019060) Gas panel - Arterial blood

862

3619

2.60

130.74

5.8

4.4

—

(3016502) Oxygen saturation in Arterial blood

1186

5795

2.29

128.43

9.3

6.7

94.3

95.7

9.23

1152

5566

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

459

1365

3.55

128.20

1.5

1.4

iu/ml

9.6

18.5

0.91

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

544

1803

3.21

127.76

1.6

1.7

u/l

36.1

38.5

1.65

464

1536

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

241

435

5.72

127.30

1.3

1.2

—

(3018418) pH of Serum or Plasma

2444

15639

1.92

127.01

6.9

3.9

7.4

0.84

630

2876

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

301

663

4.72

126.71

1.7

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

301

676

4.63

123.70

1.6

1.3

—

(3028026) IgM [Mass/volume] in Serum or Plasma

674

2568

2.82

123.43

2.0

1.8

g/l

1.3

1.4

0.60

620

2286

(40767503) Oxygen content in Capillary blood by calculation

403

1134

3.73

122.18

3.3

2.3

15.3

16.1

3.22

217

602

(3036481) Cortisol [Moles/volume] in Serum or Plasma

882

3926

2.45

117.41

2.7

2.2

nmol/l

398.5

375.4

1.68

820

3575

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

782

3300

2.56

116.64

1.7

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

259

540

4.96

116.38

1.8

1.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

4029

30697

1.86

116.23

8.3

4.7

mmol/l

6.9

0.59

3902

28814

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

286

649

4.57

115.97

1.5

1.3

—

(3000991) Gas panel - Venous blood

991

4678

2.33

115.38

10.7

7.4

—

(3023419) Bacteria identified in Sputum by Culture

266

573

4.80

114.96

2.2

2.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

874

3916

2.43

114.50

1.9

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

306

743

4.28

113.75

1.5

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1012

4847

2.30

113.75

2.5

2.1

g/l

0.2

21.38

929

4465

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

403

1201

3.52

111.93

1.7

1.6

iu/ml

3.9

12.2

0.62

102

281

(3033658) Prothrombin time (PT) actual/Normal

2054

12829

1.89

111.66

7.6

3.9

80.5

84.2

8.22

2004

12506

(3028626) Oxygen [Partial pressure] in Capillary blood

411

1246

3.46

111.14

3.7

2.5

kpa

7.8

7.9

1.21

383

1131

(3022313) Gas panel - Capillary blood

637

2493

2.73

110.33

5.7

3.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

246

519

4.89

108.96

3.5

3.6

—

(3017181) Myelocytes/100 leukocytes in Blood

900

4239

2.31

104.62

5.1

3.8

1.1

0.9

0.85

366

1267

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1704

10194

1.92

104.46

2.1

1.7

mg/l

2.0

1.5

5.50

1425

7866

(40760892) CBC W Ordered Manual Differential panel - Blood

1624

9586

1.93

103.51

6.9

4.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1293

7052

2.05

103.40

3.0

2.4

1.9

1.7

4.69

1151

6125

(46235355) HIV 1 and 2 tests - Meaningful Use set

993

4911

2.21

102.45

1.8

1.6

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

688

2911

2.53

101.38

9.7

8.3

mmol/l

24.9

24.0

8.41

640

2668

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2385

15986

1.79

100.62

3.4

2.5

u/l

57.3

59.1

0.53

2230

14706

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2945

21020

1.75

99.53

5.7

4.0

ng/l

65.7

89.7

0.44

2451

16036

(3002179) Metamyelocytes/100 leukocytes in Blood

823

3812

2.33

99.15

4.8

3.7

0.7

0.18

269

877

(3021901) Oxygen saturation in Capillary blood

356

1059

3.50

98.98

3.5

2.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

852

4025

2.29

97.93

5.1

3.9

0.2

0.1

0.25

346

1172

(3015235) Bicarbonate [Moles/volume] in Capillary blood

430

1450

3.11

97.47

3.9

2.7

mmol/l

25.5

24.4

4.32

382

1236

(3002032) Base excess in Venous blood by calculation

1043

5447

2.10

92.84

5.9

3.6

mmol/l

2.3

1.7

5.14

876

4343

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1043

5458

2.09

92.29

5.9

3.6

kpa

6.0

5.8

7.78

1009

5272

(3002582) Erythrocytes [#/volume] in Urine

2432

16720

1.74

91.65

4.3

3.4

e6/l

142.4

120.4

0.18

1970

13097

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

445

1585

2.94

91.50

10.1

3.6

u/ml

213.0

60.2

4.20

438

1524

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2141

14209

1.77

91.30

2.8

2.3

mg/l

3.4

3.0

9.41

1865

11933

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

4682

38599

1.82

91.03

14.7

7.4

u/l

90.1

80.4

20.35

4548

36057

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

199

409

4.99

90.84

1.7

1.4

—

(3026782) Osmolality of Urine

1756

11016

1.82

90.44

3.7

2.8

mosm/kgh2o

517.8

561.1

16.71

1564

9360

(3028271) Lactate [Moles/volume] in Capillary blood

293

815

3.72

90.03

2.4

1.8

mmol/l

1.7

0.64

287

793

(3000494) Fungus identified in Specimen by Culture

1033

5444

2.07

89.46

1.8

1.4

—

(3012544) pH of Venous blood

1061

5661

2.05

88.79

6.0

3.7

7.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1014

5327

2.08

88.49

10.4

7.2

g/l

116.1

120.1

8.50

988

5128

(40758558) Short blood count panel - Blood

1902

12306

1.78

87.83

12.6

6.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2185

14819

1.72

84.81

4.7

3.1

u/l

41.0

36.8

0.65

2064

13928

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

158

283

5.70

84.04

1.5

1.4

—

(3025159) Blasts/100 leukocytes in Blood

773

3739

2.22

83.13

5.2

3.9

0.3

0.2

0.16

292

965

(3021589) Normoblasts [#/volume] in Blood

2865

21046

1.66

81.28

18.5

9.8

e9/l

0.0

0.04

2347

17087

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

169

332

5.20

81.24

1.5

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

147

255

5.88

80.86

3.4

3.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

155

283

5.59

80.78

1.5

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

2338

16364

1.68

79.42

3.6

2.6

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2482

17651

1.67

79.27

5.8

3.3

mmol/l

2.3

9.26

2220

15020

(3030467) Casts [#/volume] in Urine by Automated count

2207

15240

1.69

78.75

4.1

3.3

e6/l

0.7

0.5

3.51

1753

11686

(3023520) Reticulocytes [#/volume] in Blood

985

5327

2.01

78.59

3.2

2.4

e9/l

69.2

67.2

0.90

745

4076

(3014576) Chloride [Moles/volume] in Serum or Plasma

1232

7204

1.88

77.88

10.2

6.4

mmol/l

103.3

104.6

14.12

1200

7046

(3004588) Protein electrophoresis panel - Serum or Plasma

814

4123

2.12

77.56

2.2

2.3

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

310

986

3.25

77.27

1.3

1.2

titre

508.6

89.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

783

3913

2.14

77.24

1.8

1.5

—

(36304419) Bacteria [Presence] in Urine

2121

14555

1.69

77.10

4.0

3.3

—

(3033799) Differential panel - Peritoneal fluid

110

148

7.55

77.05

2.0

1.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

229

598

3.94

76.95

1.8

1.6

g/l

1.0

0.9

0.21

172

452

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

509

2130

2.51

76.03

6.6

3.5

mmol/l

25.6

24.6

9.13

482

1916

(3023487) Leukocytes [#/volume] in Peritoneal fluid

116

170

6.93

75.26

1.8

2.3

e6/l

1272.6

5877.9

0.50

119

(3034860) Kappa light chains.free [Mass/volume] in Serum

478

1966

2.55

73.99

2.8

3.1

mg/l

69.9

93.7

0.38

372

1614

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

477

1962

2.55

73.83

2.8

3.1

mg/l

73.0

50.5

0.40

373

1612

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

628

2927

2.27

73.49

1.7

1.6

g/l

1.7

1.5

2.07

523

2487

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1007

5614

1.94

73.15

5.4

3.5

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

590

2687

2.32

72.90

6.1

3.9

mmol/l

24.2

23.9

1.20

545

2383

(3018095) Leukocytes [#/volume] in Urine

2579

18819

1.63

72.47

5.2

3.9

e6/l

115.8

110.8

0.10

2032

13907

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

466

1915

2.55

72.23

2.9

3.1

ratio

1.7

2.7

1.03

138

(3000850) Epithelial cells [#/volume] in Urine

1774

11785

1.70

71.77

3.5

2.7

e6/l

5.3

4.3

1.18

1612

10300

(40760888) Immunoglobulin light chains.free panel - Serum

386

1458

2.75

70.82

2.7

3.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

706

3505

2.14

70.51

2.1

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

813

4259

2.04

70.35

1.8

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1658

10866

1.71

70.26

5.4

4.0

ng/l

448.6

523.3

0.24

1446

9278

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

948

5255

1.95

69.78

4.5

2.9

ng/l

366.4

245.6

8.34

887

4814

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

106

153

7.03

69.74

1.7

2.1

e6/l

15191.1

19544.5

0.12

(3022217) INR in Platelet poor plasma by Coagulation assay

1366

8506

1.77

69.30

33.7

29.8

inr

1.6

1.5

1.56

186

1180

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

242

707

3.52

68.98

7.7

6.4

mg/l

12.1

0.01

226

643

(4281824)

169

391

4.41

66.74

1.3

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

543

2485

2.30

66.12

1.4

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

159

357

4.54

65.22

1.9

1.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

1019

5943

1.85

63.68

2.1

1.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1820

12485

1.64

63.62

3.3

2.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

348

1320

2.73

63.24

2.8

2.4

g/l

3.8

3.6

1.37

335

1252

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

265

865

3.15

63.18

7.4

4.5

iu/ml

424.2

3213.9

0.76

128

(3028192) IgG subclass 2 [Mass/volume] in Serum

155

356

4.44

61.79

1.5

1.3

g/l

2.9

3.0

0.20

104

251

(4062490)

155

356

4.44

61.79

1.6

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

306

1103

2.86

61.23

3.4

2.6

umol/l

32.9

34.6

0.53

266

902

(3027135) IgG subclass 1 [Mass/volume] in Serum

154

356

4.41

60.89

1.5

1.3

g/l

7.3

6.7

0.88

103

250

(3024139) IgG subclass 3 [Mass/volume] in Serum

154

356

4.41

60.89

1.5

1.3

g/l

0.5

0.4

0.42

103

250

(3015171) Extractable nuclear Ab [Units/volume] in Serum

365

1448

2.61

60.65

1.3

1.2

u/ml

0.7

0.6

0.21

136

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

688

3575

2.04

60.39

11.4

7.9

1.4

1.3

1.74

681

3550

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

686

3567

2.04

60.09

11.6

7.9

0.6

0.7

1.71

678

3539

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

13.86

59.57

1.1

1.0

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2595

19591

1.55

59.32

4.0

2.8

ug/l

232.4

157.4

20.86

2401

17705

(3044007) Cell count panel - Peritoneal fluid

136

6.85

59.22

1.8

1.9

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

326

1238

2.72

59.07

2.8

2.1

g/l

123.6

127.9

2.09

240

903

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

965

5655

1.83

59.01

3.6

2.7

umol/l

9.4

0.01

850

4932

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1114

6841

1.76

58.13

1.3

iu/ml

56.7

38.9

1.68

380

2058

(3002331) Protein [Mass/volume] in Peritoneal fluid

107

7.56

56.34

1.4

1.3

g/l

32.1

25.6

2.32

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

161

409

4.01

56.20

1.2

1.1

u/ml

—

(3024354) Oxygen [Partial pressure] in Venous blood

805

4527

1.89

55.87

5.2

3.0

kpa

4.8

4.5

2.73

770

4356

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

397

1709

2.41

55.39

1.3

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

123

6.91

54.56

1.2

1.7

g/l

16.6

13.4

1.97

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

788

4436

1.89

54.43

6.5

3.7

mmol/l

1.2

6.39

734

3827

(3008152) Bicarbonate [Moles/volume] in Arterial blood

673

3594

1.98

54.43

9.6

6.3

mmol/l

25.3

24.2

9.94

637

3351

(40761536) Microorganisms panel - Urine sediment

735

4045

1.92

54.40

5.3

4.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

3994

33434

1.53

54.36

5.8

4.8

e6/l

1018.8

1745.4

0.64

560

(3013707) Erythrocyte sedimentation rate by Westergren method

4207

35663

1.54

53.58

6.5

4.0

mm/h

22.6

13.6

120.71

3987

32461

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

324

1289

2.60

53.45

2.3

2.2

83.6

88.2

2.58

312

1220

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

231

769

3.08

53.23

1.4

1.2

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

211

673

3.21

52.27

3.2

2.3

u/ml

1170.7

2962.9

0.75

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2949

23303

1.50

52.05

5.8

4.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

189

570

3.39

51.26

6.1

3.6

u/ml

104.6

29.8

2.38

184

550

(3004809) Band form neutrophils/100 leukocytes in Blood

258

935

2.83

51.06

3.6

3.3

1.6

0.03

215

688

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

309

1230

2.59

50.90

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

309

1230

2.59

50.90

1.5

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

309

1234

2.58

50.56

2.8

1.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

166

476

3.55

48.68

1.6

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

160

448

3.64

48.63

1.6

—

(3003181) Sodium [Moles/volume] in Urine

254

941

2.77

48.22

1.5

1.3

mmol/l

58.2

62.8

1.04

189

762

(40768804) Tissue Pathology biopsy report

2501

19353

1.48

47.54

2.6

2.2

—

(3037756) Immunofixation for Serum or Plasma

314

1302

2.49

47.46

1.4

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1474

10209

1.58

47.01

4.3

3.1

mmol/l

2.5

20.73

1310

8838

(44806118)

169

503

3.42

46.81

1.7

1.3

—

(44790047)

169

503

3.42

46.81

1.7

1.3

—

(44790049)

169

503

3.42

46.81

1.7

1.3

—

(44790048)

169

503

3.42

46.81

1.7

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

293

1196

2.52

45.78

2.5

221.5

203.0

2.66

286

1139

(3037467) Urinalysis macro (dipstick) panel - Urine

4014

34263

1.47

44.74

5.9

4.5

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

770

4581

1.78

43.86

2.8

2.4

u/l

32.0

37.9

2.44

666

3899

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

146

413

3.60

43.72

1.5

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

146

413

3.60

43.72

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

146

413

3.60

43.72

1.5

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

299

1259

2.44

43.69

3.7

2.9

mg/l

2.1

1.7

8.28

276

1121

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

473

2403

2.05

43.69

2.4

1.9

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

559

3013

1.94

43.62

12.6

8.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

409

1968

2.15

43.62

2.6

2.2

ug/l

403.0

649.3

1.21

389

1870

(3007566) Smooth muscle Ab [Titer] in Serum

269

1093

2.53

42.43

1.2

titre

110.4

84.1

0.64

(4010399)

590

3286

1.88

41.60

1.5

1.4

—

(3026008) Bacteria identified in Urine by Culture

2100

16050

1.46

40.81

3.6

3.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

145

430

3.43

40.42

1.2

1.1

iu/ml

2.7

2.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

408

2031

2.08

39.75

2.7

3.4

u/ml

5187.3

2340.1

0.42

336

1741

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

434

2215

2.03

39.51

2.2

1.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

362

1728

2.16

39.34

2.8

2.2

g/l

0.1

0.0

0.48

331

1556

(3037692) Legionella sp identified in Specimen by Organism specific culture

150

5.25

38.48

1.6

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

261

1095

2.44

38.43

1.2

titre

972.5

964.8

—

(3036489) Thrombin time

353

1685

2.16

38.36

2.3

2.0

22.0

21.9

0.16

331

1517

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1270

8856

1.54

38.20

3.7

3.1

e6/l

2.3

1.8

1.60

701

5080

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

857

5455

1.66

37.80

2.9

2.4

ug/l

7.6

7.0

0.27

746

4693

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

337

1602

2.17

37.00

2.7

2.2

g/l

0.0

0.82

307

1435

(3018405) Lactate [Moles/volume] in Arterial blood

404

2059

2.03

36.88

5.9

3.6

mmol/l

1.3

1.5

1.85

395

2026

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

204

778

2.68

36.62

1.6

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1594

11744

1.48

36.58

2.0

1.8

nmol/l

1259.9

1148.4

4.22

1224

8711

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

672

4040

1.74

36.57

5.5

3.8

ng/l

120.3

98.6

5.16

572

3419

(3000492) Spirometry study

634

3758

1.76

36.24

1.7

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

119

334

3.61

36.11

1.2

1.1

titre

285.9

112.5

0.95

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

331

1579

2.16

36.01

2.8

2.2

g/l

0.0

0.00

307

1430

(3020891) Body temperature

426

2231

1.98

36.00

7.2

4.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

446

2380

1.94

35.67

2.6

2.2

—

(3011412) CD3 cells [#/volume] in Blood

128

380

3.42

35.65

2.2

2.1

e9/l

0.9

1.1

0.73

238

(3017569) Oxygen content in Arterial blood

242

4.10

35.64

2.4

2.0

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

446

2382

1.94

35.58

2.6

2.2

g/l

7.7

7.4

2.80

349

1713

(3026493) Urate [Moles/volume] in Serum or Plasma

1826

13878

1.44

35.41

3.8

2.8

umol/l

4197.5

6084.1

1.09

1572

11778

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

419

2195

1.97

35.36

2.7

2.2

g/l

3.4

3.0

9.75

345

1680

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

444

2375

1.94

35.25

2.6

2.2

g/l

4.0

3.8

1.35

344

1646

(3035637) Corticotropin [Mass/volume] in Plasma

160

547

2.98

35.25

1.5

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

290

1332

2.23

34.66

3.1

nmol/l

0.9

0.8

0.83

226

1005

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

11.31

34.44

2.5

2.0

65.3

64.2

0.04

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

386

1986

2.00

34.28

2.8

2.3

g/l

0.5

1.2

5.85

338

1671

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

239

1015

2.41

34.27

1.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

304

1442

2.16

33.54

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

415

2210

1.94

33.36

2.6

2.2

g/l

10.7

10.3

0.67

370

1828

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

959

6457

1.57

33.24

1.3

1.2

u/ml

32.4

14.0

2.49

322

2304

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

196

771

2.59

33.08

1.2

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1089

7552

1.53

33.05

1.7

1.5

g/l

3.1

2.6

5.84

760

4352

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

180

679

2.70

33.03

1.6

1.4

u/ml

115.2

122.8

0.35

145

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

242

1054

2.35

32.78

1.3

1.2

u/ml

14.2

46.0

2.28

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

204

822

2.53

32.76

1.3

1.2

u/ml

3.0

3.6

0.13

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

229

976

2.40

32.58

1.3

1.2

u/ml

4.1

2.7

0.58

(21494815) CD4 cells/100 lymphocytes in Specimen

111

319

3.52

32.53

2.2

2.1

47.0

41.8

0.39

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

231

992

2.38

32.31

1.3

1.2

u/ml

5.1

6.9

0.31

161

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2095

16552

1.40

31.87

2.6

2.1

u/l

192.2

218.2

1.30

1975

15408

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

6.71

31.80

10.9

13.2

mmol/l

4.6

5.4

1.92

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

353

1811

2.01

31.58

2.7

2.1

g/l

34.8

37.5

11.17

318

1515

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

254

1154

2.25

31.17

1.3

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

144

506

2.89

30.24

1.1

1.2

u/l

55.3

61.8

0.66

106

334

(3023420) DNA double strand Ab [Units/volume] in Serum

120

380

3.20

30.18

1.7

1.3

iu/ml

28.0

25.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

243

1100

2.26

30.09

1.3

1.1

—

(3042733) HLA Ab [Presence] in Serum

105

5.47

29.53

4.5

4.8

—

(3013512) EKG study

2008

15957

1.38

28.78

5.4

4.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

165

649

2.58

27.90

1.3

1.2

u/ml

315.8

286.3

0.59

114

395

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

273

3.52

27.90

2.4

2.1

e6/l

489.6

614.3

1.16

110

(3052851) Hemolysis interference index of Serum or Plasma

314

1626

1.98

27.34

4.5

3.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

291

3.37

26.67

1.2

u/l

112.7

90.3

0.98

245

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

127

4.76

26.58

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

106

337

3.18

26.53

1.3

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

154

602

2.60

26.39

4.3

3.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

105

336

3.16

26.01

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

138

515

2.72

25.93

1.3

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

163

663

2.50

25.72

1.6

1.5

pmol/l

468.3

206.8

2.64

154

645

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1266

9455

1.42

25.64

3.4

2.9

e6/l

1.2

1.1

0.35

700

5626

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

170

709

2.44

25.43

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

569

3595

1.64

25.34

5.5

3.2

g/l

117.6

127.6

21.48

560

3500

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

282

3.33

25.16

1.2

u/l

48.9

24.4

1.49

232

(3017354) Segmented neutrophils/100 leukocytes in Blood

147

576

2.59

25.08

3.2

3.1

60.4

59.0

0.25

344

(3037121) Protein [Mass/volume] in Urine

337

1844

1.87

24.88

3.1

3.0

g/l

0.4

0.3

0.64

194

783

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

10.04

24.70

2.4

1.8

14.4

20.4

0.27

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

243

3.49

24.46

1.5

1.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

268

3.35

24.35

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

268

3.35

24.35

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

268

3.35

24.35

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

478

2916

1.69

24.35

5.6

3.3

mmol/l

25.7

25.0

3.76

470

2823

(3026250) Tacrolimus [Mass/volume] in Blood

151

4.20

23.93

34.0

31.7

ug/l

7.1

7.3

0.29

137

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

191

3.80

23.83

1.6

1.9

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

272

3.30

23.80

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

272

3.30

23.80

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

272

3.30

23.80

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

243

3.45

23.74

1.5

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

243

3.45

23.74

1.5

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

243

3.45

23.74

1.5

1.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

283

3.25

23.66

2.0

15.1

16.0

0.15

116

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

161

678

2.41

23.60

1.1

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

188

3.81

23.56

1.6

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

188

3.81

23.56

1.6

1.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

215

1026

2.13

23.40

1.6

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

322

3.08

23.25

2.2

2.3

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

310

3.10

22.81

1.1

1.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

5.32

22.73

1.7

1.6

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

155

653

2.41

22.71

2.8

2.4

u/ml

66.6

890.5

1.14

148

640

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

446

2727

1.68

22.50

4.4

2.5

0.7

0.07

433

2605

(3016650) Hepatitis A virus Ab [Presence] in Serum

150

626

2.43

22.44

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

285

3.15

22.07

1.9

2.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

231

1161

2.03

21.91

2.6

3.3

u/ml

974.1

714.3

0.27

209

1064

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4363

47207

0.76

21.86

5.1

5.3

mmol/l

2.4

2.6

23.49

3831

42653

(21494814) CD8 cells/100 lymphocytes in Specimen

160

3.90

21.36

1.9

—

(3043409) Potassium [Moles/volume] in Arterial blood

314

1766

1.82

21.24

6.8

3.8

mmol/l

4.0

3.9

1.10

288

1656

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

346

2.89

21.11

1.3

1.1

u/ml

62.6

46.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3262

28626

1.29

21.09

4.7

3.1

u/l

79.1

54.6

14.01

3017

25992

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

252

3.24

21.09

2.4

2.2

e6/l

458.5

533.2

0.50

216

(3038026) Centromere Ab [Units/volume] in Serum

100

352

2.87

21.05

1.3

1.1

u/ml

24.1

61.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1546

12272

1.34

20.95

4.9

3.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

196

946

2.11

20.74

1.3

1.2

—

(3024928) Oxygen saturation in Venous blood

232

1197

1.97

20.45

4.9

2.9

—

(3004451) EKG impression Narrative

292

3.01

19.95

1.3

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

135

571

2.39

19.66

1.1

g/l

1.7

1.5

2.59

122

509

(40768446) Kidney Pathology biopsy report

152

3.84

19.58

1.5

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

175

3.63

19.57

35.0

23.5

ug/l

138.7

107.4

1.62

148

(3047181) Lactate [Moles/volume] in Blood

299

1704

1.79

19.37

8.1

5.7

mmol/l

1.3

0.04

267

1516

(4015189)

123

4.17

19.27

1.7

1.9

—

(3045142) Bone marrow Pathology biopsy report

142

620

2.32

19.25

1.4

1.3

—

(3008295) Osmolality of Serum or Plasma

124

511

2.46

19.13

1.4

1.3

mosm/kgh2o

273.7

278.5

1.26

383

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

6.93

19.07

2.8

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

1630

13193

1.32

18.97

5.5

4.2

estimate

0.0

0.02

735

4110

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

238

3.18

18.94

2.6

2.2

e9/l

0.2

1.87

214

(3024932) HLA-DR beta [Type]

113

4.27

18.72

1.0

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4208

45467

0.78

18.54

4.7

mmol/l

1.4

9.55

3707

40986

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

5066

47436

1.34

18.52

37.5

16.3

mg/l

33.2

27.3

27.93

4785

38559

(3005322) IgE [Units/volume] in Serum or Plasma

361

2206

1.67

18.23

1.5

1.3

u/ml

223.6

237.3

0.15

331

2005

(3051651) Icteric interference index of Serum or Plasma

313

2.84

18.22

5.1

3.6

—

(3025941) Bacteria identified in Stool by Culture

383

2377

1.65

18.22

1.4

1.3

—

(3019977) pH of Arterial blood

292

2.90

18.14

2.5

2.3

7.4

0.01

(3021601) Nitrite [Presence] in Urine by Test strip

2735

23770

1.27

17.96

6.4

5.1

estimate

0.0

0.50

801

4368

(3024471) HLA-A [Type]

117

4.13

17.91

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

124

527

2.38

17.90

3.8

3.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

145

660

2.23

17.84

1.4

—

(3025315) Body weight

6.95

17.79

4.5

5.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

142

643

2.24

17.70

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

142

644

2.23

17.63

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

142

647

2.22

17.44

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

116

4.07

17.26

2.8

2.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

168

824

2.07

17.10

5.0

3.1

—

(3009261) Glucose [Presence] in Urine by Test strip

2758

24083

1.26

17.10

5.0

3.9

estimate

0.0

0.03

768

4230

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

141

646

2.21

17.09

1.4

—

(40768797) Stomach Pathology biopsy report

899

6742

1.39

17.09

1.3

1.2

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

382

2413

1.62

16.94

7.4

4.8

1.7

1.6

1.09

361

2262

(3019225) pH of Specimen

759

5542

1.42

16.84

6.7

4.4

—

(3035350) Ketones [Presence] in Urine by Test strip

2724

23782

1.26

16.81

4.9

3.8

estimate

0.0

0.50

790

4320

(3024522) Salmonella sp identified in Specimen by Organism specific culture

141

652

2.19

16.72

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

4.26

16.39

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

148

3.60

16.39

1.8

1.9

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4277

45917

0.79

16.36

4.7

mmol/l

4.2

4.4

24.45

3797

41691

(3016038) Potassium [Moles/volume] in Urine

346

2.62

16.10

1.2

mmol/l

35.2

35.3

0.01

294

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

292

2.76

15.84

1.6

u/l

6.0

7.2

0.23

137

(3040151) Glucose [Moles/volume] in Capillary blood

137

651

2.13

15.20

9.1

19.0

mmol/l

7.1

7.5

0.89

122

518

(3044242) Glucose [Moles/volume] in Arterial blood

290

2.71

14.93

2.2

1.9

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

268

2.78

14.89

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

268

2.78

14.89

1.5

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

103

4.00

14.74

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

136

655

2.10

14.59

1.1

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

239

2.87

14.48

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

145

720

2.04

14.34

1.3

1.2

u/ml

44.8

42.0

0.07

(21494890) Protein electrophoresis panel - 24 hour Urine

132

633

2.11

14.33

1.9

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

241

2.84

14.26

1.2

1.1

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

288

2.66

14.05

1.3

1.4

u/l

23.7

28.3

0.66

232

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

355

2305

1.57

14.03

3.9

3.2

pmol/l

4.2

4.4

3.68

296

2007

(3007930) Methemoglobin/Hemoglobin.total in Blood

363

2371

1.56

13.98

7.7

4.9

0.8

0.9

2.94

344

2226

(40768441) Liver Pathology biopsy report

306

2.60

13.98

1.6

1.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

214

2.92

13.66

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

4.93

13.55

1.2

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

228

2.83

13.32

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

228

2.83

13.32

1.1

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

118

559

2.13

13.25

1.1

—

(3044927) Protein electrophoresis panel - Urine

130

640

2.05

13.20

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

162

3.17

12.97

2.5

1.8

u/ml

570.0

24575.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

4.25

12.88

2.1

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

193

1093

1.79

12.87

1.5

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4180

44627

0.81

12.84

7.0

6.5

mmol/mol

41.7

40.9

4.77

3736

40594

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

280

2.59

12.68

3.2

3.5

—

(3021788) Differential panel - Synovial fluid

169

932

1.84

12.31

1.6

1.5

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1021

12601

0.77

12.24

1.7

1.6

mmol/l

1.4

1.3

1.08

830

10452

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

366

2.34

12.06

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

236

1441

1.66

12.03

1.6

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

373

2.32

12.00

1.4

—

(3002256) Pathology report gross observation

856

6705

1.32

11.98

1.3

1.4

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

3.92

11.97

5.8

3.9

u/l

42.0

41.0

0.04

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

208

2.81

11.97

2.7

2.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4129

43983

0.82

11.52

4.2

mmol/l

1.3

0.82

3625

39239

(3014271) Vancomycin [Susceptibility]

356

2.32

11.44

2.9

3.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1411

11839

1.25

11.34

1.8

1.7

pmol/l

22775336.7

29495771.3

0.16

1146

9571

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

124

637

1.97

11.24

1.7

1.5

66.3

62.4

0.61

410

(3016750) Collection duration of Urine

330

2.35

11.07

2.0

min

501.7

490.0

0.33

233

(3021960) Folate [Moles/volume] in Serum or Plasma

1587

13516

1.23

11.07

1.8

1.6

nmol/l

19.8

20.0

0.13

1406

11454

(3012565) Volume of 24 hour Urine

229

2.64

11.02

2.5

2.3

1910.8

1895.7

0.04

191

(3001964) Herpes simplex virus Ag [Presence] in Specimen

117

3.35

10.92

2.2

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

2608

23362

1.20

10.75

2.9

2.4

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2206

19461

1.21

10.72

2.6

2.2

nmol/l

76.9

78.7

1.73

1971

16979

(21494755) Public health laboratory ask at order entry panel

109

2066

0.52

10.64

1.4

—

(40768795) Lymph node Pathology biopsy report

459

2.11

10.62

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

306

2.37

10.57

1.2

1.1

—

(3017732) Neutrophils [#/volume] in Blood

437

3150

1.42

10.34

4.0

3.3

e9/l

4.5

4.2

0.93

322

2266

(3051611) Lipemic interference index of Serum or Plasma

114

588

1.96

10.26

4.8

3.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

336

2.28

10.21

1.0

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

5.01

10.03

1.2

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

201

2.65

9.90

3.7

4.0

58.7

53.0

1.18

191

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

213

2.60

9.85

1.1

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

231

2.52

9.82

5.8

4.2

mg/l

56.8

69.4

0.97

159

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2065

18229

1.20

9.73

5.4

4.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

127

3.08

9.60

2.7

2.0

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

563

4298

1.34

9.35

2.0

1.7

1.8

1.6

6.65

468

3621

(42529582) MDA5 Ab [Presence] in Serum by Line blot

109

3.22

9.28

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

109

3.22

9.28

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

109

3.22

9.28

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

109

3.22

9.28

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

289

2.30

9.11

1.5

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

289

2.30

9.11

1.5

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

283

2.31

9.09

2.8

1.8

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

240

2.43

9.09

2.2

2.7

45.4

35.3

1.91

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

3.98

9.03

1.3

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4412

46366

0.84

8.84

5.2

5.1

mmol/l

6.2

6.1

2.72

3888

41342

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

150

2.81

8.82

2.0

u/l

16.9

50.3

1.28

140

(40757373) Influenza virus identified in Isolate

104

3.18

8.61

1.9

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

105

561

1.89

8.58

1.2

u/ml

2.9

4.9

1.86

247

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

106

577

1.85

8.19

1.2

u/ml

4.7

3.5

0.23

180

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

151

2428

0.61

8.15

1.7

1.8

—

(3003338) MCHC [Mass/volume]

3569

38061

0.86

8.14

46.1

21.8

g/l

328.1

332.0

107.33

3520

37643

(3009214) Lutropin [Units/volume] in Serum or Plasma

139

823

1.70

8.09

1.4

u/l

12.9

10.0

1.28

112

655

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

109

602

1.82

8.05

3.4

nmol/l

5.4

17.0

0.69

109

592

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

3.65

7.72

1.2

1.3

ug/l

88.8

113.6

0.37

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

311

2.13

7.69

1.0

mg/l

335.7

281.2

2.91

273

(21494434) Karyotype in Bone marrow

513

1.86

7.56

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

401

1.98

7.56

1.4

1.2

—

(3000012) Reticulocyte production index

340

2.07

7.55

1.4

1.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

5.61

7.53

3.9

3.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

5.18

7.44

1.1

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1776

19890

0.85

7.42

4.2

4.7

21.1

22.2

2.93

926

10519

(3047007) Chlamydophila sp Ab [Presence] in Serum

471

1.88

7.22

1.2

—

(3004775) Volume in Urine collected for unspecified duration

493

1.86

7.19

2.2

606.2

639.9

0.36

304

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

129

777

1.67

7.10

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

148

926

1.61

7.02

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

5.19

6.96

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

5.19

6.96

1.0

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

214

1465

1.48

6.77

1.4

1.5

ug/g

240.5

266.2

1.03

139

884

(3003694) ABO and Rh group [Type] in Blood

1383

12101

1.18

6.76

1.4

1.3

—

(3019174) dRVVT (LA screen)

5.01

6.70

1.4

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

150

2.54

6.66

2.8

1.7

ug/l

119.2

59.1

0.93

143

(3030981) Hyaline casts [#/volume] in Urine by Automated count

419

3222

1.32

6.66

4.1

2.9

e6/l

0.3

0.01

412

3155

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

493

1.82

6.59

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1546

0.57

6.58

1.4

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

501

1.81

6.56

1.7

1.5

21.1

26.9

1.22

320

(3039000) Anion gap in Blood

184

1230

1.51

6.55

10.6

6.6

mmol/l

10.6

11.4

2.93

168

1098

(3018572) Chloride [Moles/volume] in Blood

184

1230

1.51

6.55

10.6

6.6

mmol/l

104.1

105.3

2.46

168

1098

(3047189) Immunofixation for 24 hour Urine

299

2.05

6.48

1.8

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

240

2.18

6.45

1.5

1.3

u/ml

0.8

1.7

0.55

119

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

159

2.46

6.41

1.6

2.1

umol/l

121.7

103.5

0.25

(3000475) Leukocytes [#/volume] in Synovial fluid

189

1278

1.49

6.38

1.8

1.5

e6/l

18585.2

15799.1

0.28

147

911

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

282

2.07

6.31

2.6

2.4

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

480

1.80

6.24

1.0

1.1

—

(3049717) Cytology report of Urine Cyto stain

357

2710

1.34

6.22

2.9

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

146

940

1.57

6.19

1.4

1.3

u/l

61.3

41.2

1.12

127

816

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

3.96

6.16

2.7

mg/l

2.0

1.2

0.41

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

512

4097

1.27

6.03

4.0

2.7

ml/min/173m2

51.4

61.4

7.37

267

1723

(3050794) Legionella sp Ab [Presence] in Serum

4.29

6.02

1.0

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1131

0.53

5.92

2.6

1.6

mg/l

8.5

3.3

0.96

794

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

140

903

1.56

5.91

1.7

iu/l

3.2

4.5

1.07

275

(3043410) Blood group antigens tested for on Red Blood Cells

154

2.41

5.85

1.5

1.9

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

3.29

5.85

3.1

2.6

—

(3028433) Virus identified in Specimen by Culture

149

2.42

5.77

1.3

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

252

2.07

5.74

1.1

u/l

122.2

91.8

1.35

190

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.34

5.71

1.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

253

2.06

5.68

1.1

u/l

48.9

33.6

0.68

183

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

153

2.36

5.46

1.2

1.1

u/ml

1.1

10.6

—

(4268621)

369

1.85

5.45

2.2

2.3

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

106

653

1.63

5.45

1.2

miu/ml

132.3

210.9

1.34

234

(3036603) Volume of Urine

328

1.90

5.38

1.5

1.6

1866.3

1810.8

0.08

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

112

2.60

5.37

1.1

1.3

100.3

93.0

0.43

101

(3044009) aPTT.lupus sensitive (LA screen)

4.34

5.29

1.5

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

930

0.51

5.22

1.4

1.6

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2472

22902

1.13

5.20

2.3

2.1

pmol/l

91.4

92.5

0.58

1440

12152

(3014148) Varicella zoster virus Ab [Titer] in Serum

340

1.86

5.16

1.2

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.94

5.13

1.1

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

187

1322

1.43

5.10

1.3

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1154

0.57

5.09

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

185

1312

1.42

4.97

1.3

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

186

1328

1.41

4.82

1.3

1.2

—

(1761868) Lipid panel - Serum or Plasma

1226

13741

0.87

4.78

3.3

3.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.58

4.76

7.4

4.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.88

4.75

1.1

1.3

104.5

77.5

2.17

(3044889) 12 lead EKG panel

3651

34726

1.12

4.74

5.6

4.2

—

(3011985) Renin [Units/volume] in Plasma

607

1.61

4.73

1.4

mu/l

105.7

57.9

1.00

536

(3002619) Bacteria identified in Specimen by Culture

2.61

4.55

1.3

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

110

2.46

4.53

1.1

1.2

82.8

82.0

0.06

(3045716) Anion gap in Serum or Plasma

262

1.92

4.52

2.1

mmol/l

7.9

9.6

3.45

201

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

154

2.21

4.51

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

3.15

4.48

1.5

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

134

914

1.48

4.46

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

136

2.29

4.44

1.9

1.8

—

(3009871) Measles virus Ab [Titer] in Serum

2.62

4.38

1.5

1.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

244

1.93

4.38

1.7

1.4

1.3

4.4

2.31

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

511

1.63

4.36

1.1

109.3

114.1

0.50

450

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

531

1.61

4.22

1.4

1.3

nmol/l

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

4.35

4.08

1.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.71

4.08

1.1

1.3

72.3

80.0

0.42

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

428

1.67

4.07

2.3

1.9

u/l

6934.5

2477.4

0.53

161

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.01

4.06

1.5

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.52

4.04

1.3

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

169

2.08

4.00

4.5

5.4

64.9

71.5

0.54

134

(3019832) Treponema pallidum Ab [Presence] in Serum

217

1646

1.33

3.93

1.7

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

327

1.75

3.92

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

112

2.33

3.91

1.1

1.4

81.7

80.7

0.05

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

395

1.68

3.90

1.2

1.1

88.2

94.8

1.30

367

(3010144) Erythrocytes [#/volume] in Synovial fluid

529

1.58

3.83

1.7

1.3

e6/l

236563.0

158636.4

0.33

370

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

6.01

3.81

4.0

1.8

mg/l

1.2

2.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.80

1.1

—

(3044941) Cell count panel - Synovial fluid

118

815

1.46

3.75

1.6

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

660

1.51

3.74

4.8

4.3

umol/l

342.3

344.3

0.05

556

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

556

1.55

3.74

1.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

564

1.55

3.74

1.1

1.4

pmol/l

323.1

267.2

0.52

422

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

195

1476

1.33

3.61

2.8

2.3

ug/min

244.9

106.9

1.89

105

857

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

532

1.55

3.53

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

164

2.02

3.53

2.1

2.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

164

2.02

3.53

2.1

2.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.33

3.49

1.0

1.1

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

172

1.98

3.47

2.4

1.4

umol/l

27.5

29.3

0.31

166

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

113

2.22

3.40

1.2

1.3

122.8

111.8

1.06

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

7.01

3.36

1.1

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

7.01

3.36

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

105

728

1.45

3.31

2.5

2.1

mg/l

32.7

26.9

0.49

179

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

121

2.15

3.31

1.2

1.3

g/l

0.3

1.41

(3033705) Calcium.ionized [Moles/volume] in Venous blood

118

837

1.42

3.30

3.2

2.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

213

1.84

3.21

1.4

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

3.58

3.19

1.1

1.0

—

(3048879) Bone marrow aspiration report

171

1.93

3.18

1.6

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

395

1.60

3.18

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

130

2.08

3.17

2.8

2.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

214

1.83

3.16

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2342

24801

0.91

3.14

4.8

5.4

ug/l

2.9

3.9

2.48

2033

21999

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

613

1.47

3.13

1.4

1.3

nmol/l

0.1

0.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

216

1.81

3.08

1.4

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

112

2.15

3.05

1.1

1.2

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

7.51

3.05

1.0

1.1

g/l

0.2

—

(3011648) Oxygen content in Venous blood

408

1.57

3.03

2.5

2.1

9.7

10.9

1.42

408

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

203

1.83

3.02

3.3

2.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1294

14085

0.90

3.00

3.2

3.3

ug/l

0.7

0.8

2.19

959

10061

(3017704) Immunofixation for Urine

341

1.62

2.93

1.3

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

198

1.82

2.92

1.2

ratio

1.1

0.76

(3030313) Adrenal Ab [Titer] in Serum

4.71

2.91

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.21

2.89

1.1

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

2.43

2.87

1.4

1.2

ng/l

84.2

1365.8

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.93

2.85

1.7

1.3

ml/s/173m2

1.0

—

(3002385) Erythrocyte distribution width [Ratio]

3909

37791

1.09

2.81

42.9

20.0

14.7

13.9

169.86

3834

36856

(40761539) Cells [Type] in Urine sediment by Light microscopy

137

1.97

2.79

1.4

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.65

2.79

1.1

1.6

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

339

4025

0.83

2.73

1.3

1.4

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

6.01

2.69

7.3

6.5

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

6.01

2.69

1.0

u/field

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.98

2.69

2.3

1.6

—

(4306422)

528

1.46

2.65

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.13

2.64

1.2

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

268

2204

1.23

2.64

1.2

iu/ml

86.5

130.7

2.00

760

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.66

2.62

1.6

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.66

2.62

1.6

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.66

2.62

1.6

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.46

2.61

1.0

1.1

59.4

49.7

—

(40765096) Chromosome analysis panel by Banding

177

1.81

2.59

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

7.15

2.55

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

2.23

2.53

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

783

0.65

2.49

1.4

1.3

—

(40761535) Cells panel - Urine sediment

525

4603

1.15

2.49

4.6

3.5

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.46

2.44

3.6

4.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

154

1201

1.29

2.42

1.7

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

216

1755

1.24

2.41

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.94

2.41

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.17

2.40

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

5.00

2.40

1.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

402

0.52

2.40

1.0

ng/l

47.9

45.5

0.13

252

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.34

2.39

5.1

3.8

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

401

0.52

2.38

1.0

ng/l

321.4

327.2

0.05

258

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

401

0.52

2.38

1.0

ng/l

575.6

685.5

0.71

254

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

6.25

2.37

1.6

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

469

1.45

2.31

1.4

1.6

u/ml

18.5

24.8

0.49

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.18

2.30

1.0

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.86

2.30

1.1

—

(3034426) Prothrombin time (PT)

119

1.94

2.29

1.3

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.69

2.27

1.1

1.0

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

208

1.69

2.26

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

240

1.63

2.21

1.4

1.2

—

(3041184) Isoniazid [Presence] in Urine

5.56

2.21

1.8

2.0

—

(4034850)

125

1609

0.77

2.18

14.7

11.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1872

17695

1.08

2.18

4.4

4.0

mg/mmol

22.8

9.4

9.79

1252

11317

(40768443) Skin Pathology biopsy report

266

2236

1.20

2.15

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

4217

41100

1.08

2.13

35.1

17.9

37.2

38.9

21.01

2503

26128

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

205

1.66

2.10

1.4

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

2.56

2.09

1.0

—

(3016135) IgD [Mass/volume] in Serum

5.00

2.07

1.4

1.3

mg/l

21.7

115.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

5.00

2.07

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

5.00

2.07

1.8

1.1

nmol/l

874.4

347.6

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

191

1.68

2.06

3.4

2.6

—

33.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.50

2.05

3.9

1.4

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.18

2.04

1.5

1.6

pmol/l

33.8

43.5

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

4.00

2.04

1.0

2.8

3.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

238

1.60

2.03

1.4

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

119

1.85

1.96

1.5

1.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

3.34

1.96

1.1

1.0

—

(1002224) Polysomnography panel

101

1314

0.76

1.95

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.36

1.94

1.6

1.5

umol/l

49.2

43.5

0.30

(3011325) HIV 1+2 Ab [Presence] in Serum

4.55

1.94

1.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1239

11569

1.09

1.93

4.6

3.8

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.45

1.92

1.1

u/l

6.9

9.9

0.80

(3009508) Creatinine [Moles/volume] in Urine

1798

17043

1.08

1.92

3.5

3.2

mmol/l

7.0

7.5

5.85

1464

14028

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

250

1.56

1.91

1.4

1.6

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

128

1.80

1.89

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

197

1.63

1.86

1.3

1.2

g/l

40.0

40.1

0.01

104

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

129

1.79

1.85

2.1

2.3

mmol/l

7.9

8.0

0.07

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

390

4416

0.88

1.80

1.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.06

1.80

1.2

1.1

—

(3022475) Manganese [Moles/volume] in Blood

3.05

1.80

1.3

1.4

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

5079

49972

1.08

1.78

40.9

19.5

mmol/l

138.6

139.6

110.60

4968

48599

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.34

1.77

3.3

3.9

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

438

1.40

1.74

1.3

1.4

—

(3018133) Calcium [Moles/volume] in Urine

2.22

1.73

3.3

1.7

mmol/l

1.9

2.8

0.99

(3020191) Ethanol [Moles/volume] in Serum or Plasma

322

1.46

1.73

1.3

promille

1.4

1.2

0.48

249

(3029075) Extractable nuclear Ab panel - Serum

110

1.82

1.72

1.1

1.0

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.67

1.72

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.92

1.72

3.9

1.3

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

103

1.85

1.71

1.2

mg/l

1.0

95.8

0.80

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

151

1839

0.82

1.70

1.0

1.1

—

(3012516) Albumin [Mass/volume] in Urine

1759

16734

1.07

1.68

3.5

3.3

mg/l

508.0

347.9

0.80

1207

10837

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

343

3013

1.15

1.67

2.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

5085

50071

1.08

1.66

41.2

19.7

mmol/l

4.0

12.58

4963

48616

(3038071) Oxygen [Partial pressure] in Mixed venous blood

119

1.77

1.65

10.1

8.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.03

1.64

2.4

2.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

112

1.79

1.64

1.0

1.1

pmol/l

267.8

232.8

0.27

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1123

0.77

1.63

1.7

—

(40768800) Prostate Pathology biopsy report

132

1619

0.81

1.61

1.1

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

182

1.60

1.59

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.00

1.59

1.2

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

129

1.71

1.56

1.2

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

137

1.68

1.54

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.03

1.54

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.95

1.48

1.6

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.81

1.47

8.5

7.8

—

(3022621) pH of Urine by Test strip

302

3423

0.88

1.47

3.5

3.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

293

1.44

1.45

1.9

u/field

5.0

2.5

0.33

203

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

2.50

1.45

9.1

9.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

637

0.72

1.43

1.3

1.4

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

157

1.59

1.40

2.8

1.8

ug/l

23.0

69.8

0.47

143

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.80

1.37

1.0

1.1

—

5.0

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.14

1.33

1.2

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

200

1.50

1.32

1.0

1.1

iu/ml

5.8

12.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

906

8498

1.08

1.29

1.3

1.2

u/ml

1.3

1.8

1.34

215

2130

(3019150) Specific gravity of Urine by Refractometry

1017

10786

0.93

1.29

5.6

4.3

kg/l

1.0

1.74

163

1639

(44816559) Phosphatidylethanol [Mass/volume] in Blood

676

1.26

1.28

1.8

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.89

1.28

2.5

2.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

131

0.46

1.28

1.0

1.5

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3534

34537

1.05

1.26

4.3

3.7

pmol/l

15.3

15.0

7.21

3151

30662

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4518

44454

1.06

1.23

33.5

15.7

ml/min/173m2

71.7

74.1

8.52

4063

36801

(3024869) Neuronal Ab [Presence] in Serum

100

1.70

1.23

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.91

1.22

2.3

1.7

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

2.04

1.22

1.6

1.5

0.5

0.9

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

140

1.57

1.19

10.5

8.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

213

0.56

1.19

1.3

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

349

1.35

1.18

3.7

2.4

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.11

1.18

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

170

0.53

1.18

1.3

1.4

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.88

1.18

3.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

173

1.50

1.17

2.0

2.7

umol/l

28.8

29.3

0.07

129

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

102

1.67

1.16

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.50

1.15

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

103

850

1.22

1.14

1.8

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

503

4633

1.09

1.14

2.0

2.1

ug/g

220.8

160.7

1.50

407

3596

(3014051) Protein [Presence] in Urine by Test strip

1185

0.82

1.12

2.9

2.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

113

0.44

1.12

1.0

1.5

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

2.33

1.12

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

302

1.36

1.10

2.2

1.9

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

285

1.37

1.10

1.9

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

388

0.69

1.10

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

366

4019

0.91

1.09

2.2

2.1

nmol/l

10.5

12.0

2.46

319

3465

(3051593) INR in Capillary blood by Coagulation assay

329

1.34

1.08

8.1

13.4

—

(3005033) Fetal Nuchal fold Thickness US

165

0.54

1.07

1.3

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

227

1.41

1.07

1.2

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

166

0.54

1.07

1.3

1.4

—

(3024263) Appearance of Synovial fluid

296

1.35

1.05

1.8

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

220

1.41

1.04

1.5

1.7

umol/l

27.8

10.2

0.90

141

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.96

1.03

1.1

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.06

1.02

1.0

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

180

1.45

1.00

1.0

1.1

ng/l

131.3

675.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

177

1553

1.14

0.99

1.1

u/ml

1.2

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

181

1.44

0.98

1.1

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.63

0.97

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

132

1.52

0.96

1.7

1.3

34.8

33.8

0.05

(3001729) Color of Synovial fluid

1.85

0.96

1.6

1.4

—

(3028707) Methadone [Presence] in Urine by Screen method

267

1.35

0.95

2.4

2.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

182

1.43

0.95

1.7

1.3

62.2

62.0

0.01

153

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.22

0.93

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.73

0.92

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.14

0.91

1.7

1.3

—

(3009015) Lactate [Moles/volume] in Synovial fluid

1.75

0.90

1.4

1.2

mmol/l

5.2

6.8

—

(4024509)

530

0.77

0.89

2.1

1.5

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.07

0.89

1.7

1.4

pmol/l

14.5

25.8

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

177

1.41

0.88

1.0

—

(3011288) Drugs identified in Urine by Screen method

377

1.28

0.87

2.7

2.5

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

205

0.63

0.87

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

205

0.63

0.87

1.3

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

229

0.65

0.87

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

229

1.36

0.86

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

204

0.64

0.85

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

204

0.64

0.85

1.3

1.4

—

(40761511) CBC panel - Blood by Automated count

4893

48407

1.05

0.85

32.3

15.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

643

1.20

0.82

2.1

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

498

1.23

0.82

2.1

u/field

2.0

1.8

0.10

173

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.88

0.81

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

268

2935

0.91

0.81

4.6

3.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.67

0.78

2.1

2.0

umol/l

14.3

17.6

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.67

0.78

1.1

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

115

1.48

0.76

1.6

1.5

ug/l

11.4

9.2

0.93

115

(3000034) Microalbumin [Mass/volume] in Urine

521

1.21

0.76

2.9

3.2

mg/l

132.9

45.4

0.89

399

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.64

0.75

1.3

1.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

480

0.79

0.73

1.3

1.2

mmol/l

8.3

7.5

0.58

340

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.58

0.71

1.8

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

287

0.73

0.71

1.0

1.1

u/ml

10.8

2.1

—

111

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.71

0.70

1.0

1.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.85

0.68

2.4

1.9

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

240

1.29

0.67

1.2

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.63

0.66

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.63

0.66

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

982

0.86

0.66

1.1

u/ml

9.8

8.8

—

(3008898) HLA-B27 [Presence]

991

0.87

0.65

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

569

1.18

0.64

1.3

—

(4133840)

104

1.44

0.62

1.1

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4233

42788

0.97

0.61

5.2

4.6

mu/l

2.4

2.1

0.58

3801

38229

(3010813) Leukocytes [#/volume] in Blood

5126

51639

0.96

0.61

51.4

24.2

e9/l

7.5

6.9

30.24

4980

49786

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.57

0.60

1.1

—

(3000963) Hemoglobin [Mass/volume] in Blood

5126

51634

0.96

0.59

51.6

24.3

g/l

125.6

134.1

229.92

5035

50623

(3027008) Opiates [Presence] in Urine

583

1.17

0.59

2.2

1.8

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

622

6511

0.95

0.59

4.5

4.8

33.5

32.9

0.52

439

4238

(3016018) Differential panel - Cerebral spinal fluid

427

1.20

0.58

1.2

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

114

1.40

0.58

1.3

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.51

0.58

1.5

1.3

—

208.8

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

166

1512

1.10

0.58

1.6

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.46

0.58

1.0

1.3

—

(3026361) Erythrocytes [#/volume] in Blood

5126

51624

0.96

0.57

51.2

24.1

e12/l

4.2

4.4

139.71

4970

49776

(3035941) MCH [Entitic mass]

5126

51622

0.96

0.57

51.0

24.0

30.3

30.5

13.92

5034

50606

(3024731) MCV [Entitic volume]

5126

51621

0.96

0.57

51.1

24.1

92.1

91.7

6.84

5036

50605

(3013139) Helicobacter pylori Ag [Presence] in Stool

277

2966

0.93

0.55

1.2

—

(3007461) Platelets [#/volume] in Blood

5126

51613

0.96

0.55

51.2

24.1

e9/l

249.9

238.3

19.98

4997

49972

(3020491) Glucose [Moles/volume] in Blood

366

1.20

0.55

1.7

2.1

mmol/l

6.9

7.0

0.12

238

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.42

0.54

1.0

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

806

1.13

0.53

1.5

1.4

iu/l

29.2

30.2

0.12

684

(3026389) Candida sp identified in Specimen by Organism specific culture

581

1.15

0.53

1.2

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

134

1.34

0.53

1.2

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

654

6814

0.96

0.53

14.2

8.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.41

0.50

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

136

1.32

0.49

1.1

miu/ml

1668.2

1591.3

0.12

136

(3025130) Human papilloma virus identified in Specimen

257

0.78

0.49

1.9

1.7

—

(3028300) Cannabinoids [Presence] in Urine

586

1.14

0.48

2.3

1.8

—

(4198724)

1.40

0.48

1.4

1.5

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

200

0.75

0.47

1.0

1.2

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

1.49

0.47

1.1

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

441

0.84

0.47

1.1

u/ml

9.8

2.6

0.54

145

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.46

0.46

1.1

1.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

402

1.17

0.46

1.1

—

29.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

329

1.19

0.44

5.7

5.1

u/ml

244.7

41.3

0.56

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.40

0.44

1.0

1.1

—

8.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

247

1.22

0.44

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.56

0.42

1.6

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

585

0.87

0.42

1.6

1.7

—

(3027944) Amphetamines [Presence] in Urine

575

1.13

0.42

2.2

1.8

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.40

0.42

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.43

0.41

2.7

u/field

0.7

0.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

150

0.73

0.41

1.2

1.7

—

(3027874) Urate [Moles/volume] in Urine

0.00

0.41

0.0

1.1

—

1.9

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.41

0.0

1.4

—

1.4

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

426

1.15

0.40

1.1

—

3.3

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.1

—

175.1

—

(3023511) Choriogonadotropin [Units/volume] in Urine

186

1.24

0.40

1.4

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

578

1.13

0.39

2.3

1.9

—

(3044290) Cell count panel - Cerebral spinal fluid

874

1.10

0.39

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

354

1.16

0.38

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

323

0.84

0.38

1.0

1.2

mmol/l

12.4

12.0

—

100

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

263

1.18

0.35

1.1

mg/l

272.2

304.6

0.47

224

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

199

1.21

0.35

1.9

2.2

umol/l

57.1

0.00

160

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

100

1.30

0.33

2.8

3.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

151

1611

0.94

0.33

1.6

1.7

—

(3006653) Thiamine [Moles/volume] in Blood

228

1.19

0.33

1.1

1.2

nmol/l

122.4

139.2

1.72

228

(3045414) Leukocytes [Presence] in Urine

214

2257

0.95

0.33

2.3

2.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

166

0.78

0.33

1.2

1.5

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.30

0.33

1.5

1.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

407

1.13

0.32

1.3

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

407

1.13

0.32

1.3

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

119

1.26

0.31

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

443

0.88

0.31

1.1

u/ml

0.4

2.5

2.52

175

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.27

0.30

2.3

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

743

0.91

0.28

1.6

1.8

—

(40758292) HTLV I+II Ab panel - Serum

1.29

0.28

1.1

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.26

0.26

1.5

1.6

—

(3016879) Cocaine [Presence] in Urine

539

1.10

0.26

2.4

1.9

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.67

0.25

1.6

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

453

1.10

0.25

2.1

1.8

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

235

1.15

0.25

7.5

6.5

—

(3035933) Granulocytes/100 leukocytes in Blood

1.28

0.24

2.0

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

514

5011

1.03

0.23

1.4

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

688

1.08

0.23

1.1

iu/ml

150.2

1193.6

0.59

140

(3006462) Nitrate [Presence] in Urine

248

1.13

0.21

4.0

3.9

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

1.9

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

2.4

—

2.6

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.0

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.22

0.20

1.7

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

155

1.16

0.19

1.1

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

279

1.11

0.19

1.2

1.1

mg/l

41.9

44.4

0.12

229

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

118

1.19

0.19

1.2

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

270

0.89

0.19

1.2

1.1

nmol/l

2.6

8.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.13

0.18

27.5

11.9

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

128

1.17

0.18

1.2

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

100

1.20

0.18

1.2

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

271

1.11

0.18

1.3

nmol/l

1.2

1.1

0.05

202

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

300

1.10

0.17

1.2

1.5

nmol/l

0.2

0.23

232

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

248

2555

0.97

0.17

1.4

1.3

au/ml

34.7

60.6

1.70

108

(3025577) Chromium [Mass/volume] in Blood

397

1.08

0.17

1.7

2.0

ug/l

1.5

2.1

2.02

326

(1761482) Bacteria [#/volume] in Urine by Culture

172

1659

1.04

0.17

4.8

4.4

—

(3020961) Endomysium IgA Ab [Titer] in Serum

175

1690

1.04

0.16

1.1

titre

14.0

240.0

—

(3020650) Glucose [Presence] in Urine

101

1.19

0.16

1.4

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

173

1791

0.96

0.16

1.6

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

564

1.06

0.16

1.0

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

214

0.89

0.15

1.2

1.1

—

(36660697) Celiac disease serology panel - Serum

296

3030

0.98

0.14

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

198

1.11

0.14

1.0

1.1

u/l

1.1

1.2

0.43

101

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

114

1099

1.04

0.13

1.4

1.3

mg/l

529.4

576.6

0.47

109

1024

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.18

0.12

2.8

1.6

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

204

2091

0.97

0.12

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

158

0.89

0.12

1.4

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

954

1.04

0.12

1.4

1.3

e6/l

9.2

25.0

1.14

737

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

954

1.04

0.12

1.5

1.4

e6/l

395.3

890.2

1.18

776

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

323

0.93

0.11

2.0

2.2

ug/min

107.3

201.6

—

(44813793)

230

1.09

0.11

1.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

178

0.90

0.11

1.7

nmol/l

5.3

7.4

0.21

152

(4094501)

126

1298

0.97

0.11

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

799

1.04

0.11

1.4

1.7

mu/l

386.6

306.8

0.64

736

(1617658) Protocol used for examination of sentinel lymph nodes

280

1.07

0.10

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

106

1.13

0.09

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

381

0.94

0.09

1.0

1.1

u/ml

3.4

3.9

0.05

182

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.04

0.09

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

155

0.90

0.09

1.0

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

370

0.95

0.09

1.0

1.1

u/ml

0.5

1.7

1.36

158

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.11

0.09

1.2

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

288

0.94

0.08

1.3

1.4

pmol/l

97.1

157.4

—

(3015183) Erythrocyte sedimentation rate

144

0.90

0.08

1.0

1.2

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.81

0.08

1.2

5.1

mmol/l

7.4

8.3

—

(4211845)

273

1.06

0.08

4.3

3.7

—

(4212803)

1.09

0.08

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

280

2840

0.99

0.07

2.6

2.4

au/ml

31.5

25.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

133

0.90

0.07

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5008

50023

1.01

0.06

19.9

10.8

u/l

25.1

25.8

0.86

4880

47778

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

119

1.09

0.06

1.2

1.1

—

(40768793) Breast Pathology biopsy report

791

1.02

0.05

1.3

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

202

0.94

0.05

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

307

1.04

0.05

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

130

1.08

0.04

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

504

0.97

0.04

1.3

1.2

nmol/l

333.4

335.5

0.02

395

(3037556) Urate [Mass/volume] in Serum or Plasma

180

0.94

0.04

1.9

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

121

1.07

0.03

1.2

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

121

1194

1.01

0.03

3.3

3.7

mg/l

35.4

30.6

0.57

781

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

976

1.01

0.03

2.1

1.5

nmol/l

0.8

0.02

801

(4146454)

639

1.02

0.02

3.0

2.8

—

(44806420)

212

1.04

0.02

1.9

2.4

—

(3022689) Creatine [Moles/volume] in Urine

146

0.96

0.00

2.4

1.5

—

(3026470) Cobalt [Mass/volume] in Blood

414

1.01

0.00

1.7

1.9

ug/l

2.6

3.6

0.94

352

(3051101) Glucose [Moles/volume] in Cord blood

122

0.98

0.00

3.7

6.3

—

(4027681)

198

1.01

0.00

1.4

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

116

1.03

0.00

1.2

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

186

1.02

0.00

1.2

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

266

1.02

0.00

1.8

1.7

nmol/l

16.9

16.1

0.23

247

(3023410) Appearance of Cerebral spinal fluid

401

1.00

0.00

1.5

—

(3021374) Sirolimus [Mass/volume] in Blood

0.00

0.0

7.0

—

7.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

6.2

—

0.3

—

(3038413) Eosinophils/100 leukocytes in Peritoneal dialysis fluid by Manual count

0.00

0.0

5.8

—

14.0

—

(3028717) Thiamine [Mass/volume] in Blood

0.93

0.00

1.0

1.2

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.0

1.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.94

0.00

1.8

1.6

ng/l

135.2

155.8

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.5

—

1.3

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.3

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3022145) Colonoscopy Study observation

545

5450

1.00

0.00

1.3

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.4

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3000285) Sodium [Moles/volume] in Blood

0.92

0.00

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.02

0.00

1.0

1.1

—

(4038314)

0.00

0.0

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

0.0

1.2

—

Mortality – FinRegistry

↥

Association

Association between endpoint J10_PLEUREFFUSION and mortality.

Females

Parameter	HR [95% CI]	p-value
J10_PLEUREFFUSION	4.638 [4.08, 5.27]	< 0.001
Birth year	0.997 [0.99, 1.01]	0.508

During the follow-up period (1.1.1998 — 31.12.2019), 9071 out of 14473 females with J10_PLEUREFFUSION died.

Males

Parameter	HR [95% CI]	p-value
J10_PLEUREFFUSION	3.657 [3.22, 4.15]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.021

During the follow-up period (1.1.1998 — 31.12.2019), 13181 out of 21590 males with J10_PLEUREFFUSION died.

Mortality risk

Mortality risk for people of age

years, who have J10_PLEUREFFUSION.

N-year risk	Females	Males
1	0.516%	0.574%
5	2.675%	3.896%
10	6.238%	9.99%
15	13.027%	18.751%
20	21.6%	29.907%

Relationships between endpoints

↥

Index endpoint: J10_PLEUREFFUSION – Pleural effusion

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pleural effusion

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints